<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Integrated - Respi Endocrine - 03-09-2025 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / BTR
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">100</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 92175,
    "choices": [
      {
        "id": 367016,
        "text": "<p><span style=\"font-size:14.0pt;\">Chronic lymphocytic thyroiditis</span></p>"
      },
      {
        "id": 367017,
        "text": "<p><span style=\"font-size:14.0pt;\">Drug-induced hypothyroidism</span></p>"
      },
      {
        "id": 367018,
        "text": "<p><span style=\"font-size:14.0pt;\">Subclinical hypothyroidism</span></p>"
      },
      {
        "id": 367019,
        "text": "<p><span style=\"font-size:14.0pt;\">Euthyroid sick syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman is admitted to the intensive care unit due to severe sepsis caused by a ruptured abdominal abscess. She has been receiving high-dose intravenous corticosteroids for hypotension management over the past three days. On examination, she is alert but appears critically ill. Laboratory results are as follows:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>TSH:</strong> 1.2 \u00b5U/mL (normal range: 0.4\u20134.0 \u00b5U/mL)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Free T4:</strong> 1.1 ng/dL (normal range: 0.8\u20131.8 ng/dL)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Free T3:</strong> 0.6 pg/mL (normal range: 2.0\u20134.4 pg/mL)</span></li></ul><p><span style=\"font-size:14.0pt;\">Which of the following is the most likely explanation for these findings?</span></p>",
    "unique_key": "Q4807367",
    "question_audio": null,
    "question_video": null,
    "map_id": 33412936,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Euthyroid sick syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In severe systemic illness (like sepsis), thyroid function tests often show low T3, normal/low T4, and normal/low TSH due to impaired peripheral conversion of T4 \u2192 T3 and altered hypothalamic-pituitary regulation. Here, Free T3 is low, Free T4 is normal, and TSH is normal \u2192 classic for euthyroid sick syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chronic lymphocytic thyroiditis:</strong> Typically shows elevated TSH with low T4/T3, along with autoimmune antibody positivity.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Drug-induced hypothyroidism:</strong> Drugs like amiodarone, lithium, interferon-\u03b1 cause true hypothyroidism with \u2191 TSH and \u2193 T4.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Subclinical hypothyroidism:</strong> Characterized by \u2191 TSH with normal T4/T3, not seen in this case.</span></p>",
    "correct_choice_id": 367019,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67016,
    "choices": [
      {
        "id": 267197,
        "text": "<p><span style=\"font-size:14.0pt;\">Cortisol low, Aldosterone low, ADH high, Norepinephrine high</span></p>"
      },
      {
        "id": 267198,
        "text": "<p><span style=\"font-size:14.0pt;\">Cortisol normal, Aldosterone low, ADH normal, Norepinephrine normal&nbsp;</span></p>"
      },
      {
        "id": 267199,
        "text": "<p><span style=\"font-size:14.0pt;\">Cortisol low, Aldosterone low, ADH normal, Norepinephrine normal</span></p>"
      },
      {
        "id": 267200,
        "text": "<p><span style=\"font-size:14.0pt;\">Cortisol high, Aldosterone low, ADH high, Norepinephrine high</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old woman presents with a 3-month history of fatigue, weight loss, salt craving, and dizziness upon standing. She has no significant medical history and takes no medications. Her mother was recently diagnosed with hypothyroidism. On examination, her blood pressure is 100/70 mm Hg supine and 80/50 mm Hg standing. Laboratory results reveal the following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sodium 129 meq/l&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Potassium 5.9 meq/l&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chloride 100 meq/l&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bicarbonate 21 meq/l&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Creatinine 1.4 mg/dl&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">BUN 38 mg/dl&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following in circulating hormone levels are expected in this patient?&nbsp;</span></p>",
    "unique_key": "Q9945062",
    "question_audio": null,
    "question_video": null,
    "map_id": 33412937,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cortisol low, Aldosterone low, ADH high, Norepinephrine high</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has primary adrenal insufficiency (Addison\u2019s disease) indicated by fatigue, weight loss, salt craving, hypotension, hyponatremia, and hyperkalemia. Cortisol and aldosterone are both low, leading to hypotension and volume depletion. Compensatory mechanisms increase ADH and norepinephrine to maintain blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cortisol normal, Aldosterone low, ADH normal, Norepinephrine normal:</strong> Cortisol would be low, not normal, and compensatory hormones would be elevated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cortisol low, Aldosterone low, ADH normal, Norepinephrine normal:</strong> ADH rises in response to hypotension and hyponatremia; norepinephrine is also elevated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cortisol high, Aldosterone low, ADH high, Norepinephrine high:</strong> Cortisol is not high in adrenal insufficiency; high cortisol would suppress ADH and norepinephrine.</span></p>",
    "correct_choice_id": 267197,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 66990,
    "choices": [
      {
        "id": 267093,
        "text": "<p><span style=\"font-size:14.0pt;\">Stimulation of osteoblast activity</span></p>"
      },
      {
        "id": 267094,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased stimulation of RANK ligand (RANKL)</span></p>"
      },
      {
        "id": 267095,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased intestinal calcium absorption</span></p>"
      },
      {
        "id": 267096,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased osteoclast apoptosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old postmenopausal woman presents for evaluation of her low bone density noted during a routine screening. She is started on oral risedronate to address her bone loss. What is the primary mechanism through which this medication improves bone density?</span></p>",
    "unique_key": "Q3143127",
    "question_audio": null,
    "question_video": null,
    "map_id": 33412938,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Increased osteoclast apoptosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Risedronate is a bisphosphonate that binds to bone and induces osteoclast apoptosis, reducing bone resorption and thereby increasing bone density. Its main effect is antiresorptive, not anabolic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stimulation of osteoblast activity:</strong> Risedronate does not directly stimulate osteoblast activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Decreased stimulation of RANK ligand (RANKL):</strong> It does not affect RANKL signaling directly; it targets osteoclasts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased intestinal calcium absorption:</strong> It does not increase intestinal calcium absorption; that is the action of vitamin D.</span></p>",
    "correct_choice_id": 267096,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92176,
    "choices": [
      {
        "id": 367020,
        "text": "<p><span style=\"font-size:14.0pt;\">Activation of lactotrophs by antithyroid peroxidase antibodies&nbsp;</span></p>"
      },
      {
        "id": 367021,
        "text": "<p><span style=\"font-size:14.0pt;\">Binding of dopamine receptors by antithyroid peroxidase antibodies&nbsp;</span></p>"
      },
      {
        "id": 367022,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of dopamine release by TSH&nbsp;</span></p>"
      },
      {
        "id": 367023,
        "text": "<p><span style=\"font-size:14.0pt;\">Stimulation of lactotrophs by thyrotropin-releasing hormone (TRH)<strong>&nbsp;</strong></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman comes to the OPD due to a 4-month history of amenorrhea. She has also had a whitish nipple discharge from both breasts. The patient has taken several pregnancy tests at home that have been negative. She has also had increased fatigue, depressed mood, and weight gain over this time. The patient has had no headaches or vision changes. On physical examination, there is thinning of the outer third of the eyebrows. The thyroid is enlarged and nontender to palpation. The skin appears dry.&nbsp; Her thyroxine (T4) levels are low, TSH is elevated, and antithyroid peroxidase antibodies are positive. Prolactin levels are 30 ng/ml. Which of the following is the most likely mechanism causing this patient's elevated prolactin level?</span></p>",
    "unique_key": "Q8370831",
    "question_audio": null,
    "question_video": null,
    "map_id": 33412939,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Stimulation of lactotrophs by thyrotropin-releasing hormone (TRH)</strong></span></p><p><br><span style=\"font-size:14.0pt;\">This patient has primary hypothyroidism, indicated by low T4, high TSH, positive anti-TPO antibodies, and classic symptoms. Elevated TRH in response to low thyroid hormone stimulates lactotrophs, causing mild hyperprolactinemia and galactorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Activation of lactotrophs by antithyroid peroxidase antibodies:</strong>&nbsp;Antithyroid antibodies do not directly activate lactotrophs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Binding of dopamine receptors by antithyroid peroxidase antibodies:</strong>&nbsp;They do not bind dopamine receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Inhibition of dopamine release by TSH:</strong>&nbsp;TSH does not inhibit dopamine release; TRH is the main stimulator of prolactin</span></p>",
    "correct_choice_id": 367023,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92177,
    "choices": [
      {
        "id": 367024,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased blood pressure<strong>&nbsp;</strong></span></p>"
      },
      {
        "id": 367025,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased bone mineral density&nbsp;</span></p>"
      },
      {
        "id": 367026,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased fluid retention&nbsp;</span></p>"
      },
      {
        "id": 367027,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased postprandial satiety&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman comes to the OPD for follow-up of type 2 diabetes mellitus. The patient is taking the maximum dose of metformin. Her hemoglobinA1c is 7.7%. Blood pressure is 134/86 mm Hg, and pulse is 72/min. BMI is 33 kg/m2. Family history is significant for osteoporosis in mother. The results of other laboratory tests are normal. After discussion, a sodium-glucose cotransporter-2 inhibitor is added to the patient's drug regimen. Which of the following is the most likely additional effect of the newly prescribed medication?</span></p>",
    "unique_key": "Q9955297",
    "question_audio": null,
    "question_video": null,
    "map_id": 33412940,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Decreased blood pressure</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">SGLT-2 inhibitors lower blood glucose by promoting glycosuria and also cause <strong>mild diuresis</strong>, leading to a reduction in blood pressure. They also contribute to modest weight loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Increased bone mineral density:</strong>&nbsp;They do not increase bone mineral density; some may slightly decrease it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Increased fluid retention:</strong>&nbsp;They cause fluid loss, not retention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Increased postprandial satiety:</strong> They do not significantly affect postprandial satiety.</span></p>",
    "correct_choice_id": 367024,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92178,
    "choices": [
      {
        "id": 367028,
        "text": "<p><span style=\"font-size:14.0pt;\">Sulfonylurea overdose</span></p>"
      },
      {
        "id": 367029,
        "text": "<p><span style=\"font-size:14.0pt;\">Exogenous insulin in supplement&nbsp;</span></p>"
      },
      {
        "id": 367030,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulinoma</span></p>"
      },
      {
        "id": 367031,
        "text": "<p><span style=\"font-size:14.0pt;\">GLP-1 agonist</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man is brought to the emergency department after being found unconscious at home. He has a history of diabetes mellitus and reports recurrent episodes of hypoglycemia. His wife mentions that he has been trying a new \"natural\" supplement along with his prescribed insulin. On arrival, his blood glucose is 45 mg/dL. Laboratory tests reveal high serum C-peptide levels. Which of the following is the most likely cause of his hypoglycemia?</span></p>",
    "unique_key": "Q4125990",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413121,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Sulfonylurea overdose</strong></span></p><p><br><span style=\"font-size:14.0pt;\">High <strong>C-peptide</strong> with hypoglycemia indicates endogenous insulin overproduction, which is characteristic of a <strong>sulfonylurea overdose</strong>. Sulfonylureas stimulate pancreatic beta cells to release insulin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Exogenous insulin in supplement:</strong> Exogenous insulin causes low C-peptide levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Insulinoma:</strong> Insulinoma can cause high C-peptide, but sudden onset after a supplement suggests drug-induced hypoglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. GLP-1 agonist:</strong> GLP-1 agonists rarely cause severe hypoglycemia and usually require concurrent insulin or sulfonylurea.</span></p>",
    "correct_choice_id": 367028,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92179,
    "choices": [
      {
        "id": 367032,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased activity of RANKL&nbsp;</span></p>"
      },
      {
        "id": 367033,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased levels of osteoprotegerin&nbsp;</span></p>"
      },
      {
        "id": 367034,
        "text": "<p><span style=\"font-size:14.0pt;\">Osteoclast apoptosis</span></p>"
      },
      {
        "id": 367035,
        "text": "<p><span style=\"font-size:14.0pt;\">Stimulation of osteoblast activity&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A study is conducted to assess the effect of parathyroid hormone (PTH) on bone remodeling. Half of the study subjects receive intermittent PTH injections and the other half receive a continuous infusion of PTH. The results show that the effects on bone metabolism of intermittent PTH injections are different from those of continuous infusion. Which of the following is most likely to be the predominant bone effect with intermittent injections?</span></p>",
    "unique_key": "Q6016815",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413162,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Stimulation of osteoblast activity</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Intermittent PTH administration has an anabolic effect on bone by directly stimulating osteoblast activity, increasing bone formation and improving bone density.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Increased activity of RANKL:</strong>&nbsp;Continuous PTH, not intermittent, increases RANKL and osteoclast activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Increased levels of osteoprotegerin:</strong>&nbsp;Osteoprotegerin levels are not significantly increased by intermittent PTH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Osteoclast apoptosis:</strong> Intermittent PTH does not primarily induce osteoclast apoptosis.</span></p>",
    "correct_choice_id": 367035,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 66986,
    "choices": [
      {
        "id": 267077,
        "text": "<p><span style=\"font-size:14.0pt;\">Iodide uptake by the thyroid gland</span></p>"
      },
      {
        "id": 267078,
        "text": "<p><span style=\"font-size:14.0pt;\">Coupling of iodotyrosine</span></p>"
      },
      {
        "id": 267079,
        "text": "<p><span style=\"font-size:14.0pt;\">Peripheral conversion of T4 to T3</span></p>"
      },
      {
        "id": 267080,
        "text": "<p><span style=\"font-size:14.0pt;\">Colloid production</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents to the clinic with complaints of weight loss, heat intolerance, palpitations, and insomnia over the past 4 months. Her vital signs are blood pressure 140/85 mm Hg, pulse 110/min, and regular. On examination, the thyroid gland is diffusely enlarged and non-tender. Laboratory studies reveal decreased serum TSH and elevated free thyroxine (T4) levels. Methimazole is initiated as treatment. Which of the following processes is most likely inhibited by this treatment?</span></p>",
    "unique_key": "Q7056978",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413183,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Coupling of iodotyrosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Methimazole inhibits thyroid peroxidase, preventing the coupling of iodotyrosines to form T3 and T4, thereby reducing thyroid hormone synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Iodide uptake by the thyroid gland:</strong> Methimazole does not inhibit iodide uptake; that is the function of the sodium-iodide symporter.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Peripheral conversion of T4 to T3:</strong> It does not affect peripheral conversion of T4 to T3; drugs like propranolol or amiodarone influence that.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Colloid production:</strong> Colloid production is not directly affected by methimazole.</span></p>",
    "correct_choice_id": 267078,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92180,
    "choices": [
      {
        "id": 367036,
        "text": "<p><span style=\"font-size:14.0pt;\">Chronic autoimmune thyroiditis&nbsp;</span></p>"
      },
      {
        "id": 367037,
        "text": "<p><span style=\"font-size:14.0pt;\">Graves disease</span></p>"
      },
      {
        "id": 367038,
        "text": "<p><span style=\"font-size:14.0pt;\">Postpartum thyroiditis&nbsp;</span></p>"
      },
      {
        "id": 367039,
        "text": "<p><span style=\"font-size:14.0pt;\">Secondary hypothyroidism&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old woman comes to the OPD due to hair loss.&nbsp; The patient has fatigue and decreased libido, and her menstrual cycles have not returned since her delivery 8 months ago. The thyroid is nontender. Laboratory results show decreased serum TSH and free thyroxine (T4) levels. Which of the following is the most likely diagnosis in this patient?</span></p>",
    "unique_key": "Q8953088",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413184,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Secondary hypothyroidism&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has <strong>secondary hypothyroidism</strong> due to pituitary insufficiency, indicated by <strong>low TSH despite low T4</strong>. The failure of TSH to rise differentiates it from primary thyroid disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Chronic autoimmune thyroiditis:</strong>&nbsp;Chronic autoimmune thyroiditis usually shows high TSH in hypothyroid phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Graves disease:</strong>&nbsp;Graves disease causes hyperthyroidism, not low T4.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Postpartum thyroiditis:</strong>&nbsp;Postpartum thyroiditis usually shows transient hyperthyroidism first; low TSH with low T4 is less common.</span></p>",
    "correct_choice_id": 367039,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74377,
    "choices": [
      {
        "id": 296429,
        "text": "<p><span style=\"font-size:14.0pt;\">Early-morning cortisol level&nbsp;</span></p>"
      },
      {
        "id": 296430,
        "text": "<p><span style=\"font-size:14.0pt;\">Overnight low-dose dexamethasone suppression test</span></p>"
      },
      {
        "id": 296431,
        "text": "<p><span style=\"font-size:14.0pt;\">Serum ACTH level</span></p>"
      },
      {
        "id": 296432,
        "text": "<p><span style=\"font-size:14.0pt;\">Cosyntropin test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old woman comes to the AIIMS OPD due to a 6.8-kg weight gain over the last few months. The patient also has experienced weakness and cannot lift weights that she was able to lift before the onset of her symptoms. On examination, blood pressure is 160/100 mmHg and pulse is 88/min and regular. Neurologic examination shows proximal muscle weakness. Dark terminal hair is present on the lower abdomen. Fasting laboratory results are as follows:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sodium-142 mEq/L</span></p><p><span style=\"font-size:14.0pt;\">Potassium-3.6 mEq/L</span></p><p><span style=\"font-size:14.0pt;\">Chloride-98 mEq/L</span></p><p><span style=\"font-size:14.0pt;\">Bicarbonate-28 mEq/L</span></p><p><span style=\"font-size:14.0pt;\">Calcium-9.2 mg/dL</span></p><p><span style=\"font-size:14.0pt;\">TSH-2.2 mlU/L (N-0.5 to 5.0 mIU/L)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the most appropriate next step in evaluating this patient's condition?</span></p>",
    "unique_key": "Q8333257",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413205,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Overnight low-dose dexamethasone suppression test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has features suggestive of Cushing\u2019s syndrome (weight gain, hypertension, proximal muscle weakness, and hirsutism). The overnight low-dose dexamethasone suppression test is the first-line screening test to confirm endogenous cortisol excess.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Early-morning cortisol level:</strong> Early-morning cortisol can vary and is less sensitive for screening Cushing\u2019s syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum ACTH level:</strong> Serum ACTH is useful after confirming hypercortisolism to differentiate ACTH-dependent vs independent causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cosyntropin test:</strong> Cosyntropin (ACTH) stimulation test is mainly used to evaluate adrenal insufficiency, not Cushing\u2019s.</span></p>",
    "correct_choice_id": 296430,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73798,
    "choices": [
      {
        "id": 294133,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3 and 4</span></p>"
      },
      {
        "id": 294134,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 2 and 4</span></p>"
      },
      {
        "id": 294135,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4 and 2</span></p>"
      },
      {
        "id": 294136,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 2, 1 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Many GPCR receptors act via an increase in cAMP. The steps involved in this mechanism are given below. Which of the following is the correct sequence of events in the cAMP signal transduction pathway?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Activation of adenylate cyclase</span></li><li><span style=\"font-size:14.0pt;\">Activation of PKA</span></li><li><span style=\"font-size:14.0pt;\">Conversion of ATP to cAMP</span></li><li><span style=\"font-size:14.0pt;\">Phosphorylation of target proteins</span></li></ol>",
    "unique_key": "Q1863355",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413706,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 3, 2 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Upon ligand binding, the GPCR activates adenylate cyclase, which converts ATP to cAMP. cAMP then activates protein kinase A (PKA), which phosphorylates target proteins to produce cellular effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;</strong>Incorrect sequence: PKA cannot activate before cAMP formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;</strong>Phosphorylation occurs after PKA activation, not before.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;</strong>This order is completely reversed and physiologically incorrect.</span></p>",
    "correct_choice_id": 294134,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73805,
    "choices": [
      {
        "id": 294157,
        "text": "<p><span style=\"font-size:14.0pt;\">SIADH&nbsp;</span></p>"
      },
      {
        "id": 294158,
        "text": "<p><span style=\"font-size:14.0pt;\">Diuretic induced hyponatremia</span></p>"
      },
      {
        "id": 294159,
        "text": "<p><span style=\"font-size:14.0pt;\">Cerebral salt wasting syndrome</span></p>"
      },
      {
        "id": 294160,
        "text": "<p><span style=\"font-size:14.0pt;\">Pseudohyponatremia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old smoker who is a known case of hypertension was on enalapril and hydrochlorothiazide. He had an episode of hemoptysis and on evaluation, he was found to have bronchogenic carcinoma with brain metastasis. His lab values were Na = 124mg / d*L creatinine= 2.8 mg%, blood sugar= 112 mg/dL, blood urea= 24 mg/dL, serum osmolality= 255 mOsm, urine osmolality= 120 mOsm, 24-hour urinary sodium= 110, and BP = 150/90 mmHg. Which of the following is the most probable diagnosis of the low sodium values in him?</span></p>",
    "unique_key": "Q1552529",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413707,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) SIADH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has SIADH secondary to bronchogenic carcinoma, indicated by hyponatremia, low serum osmolality, inappropriately concentrated urine, and high urinary sodium. This is a classic paraneoplastic manifestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Diuretic induced hyponatremia:</strong> Diuretic-induced hyponatremia usually presents with volume depletion, which is not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diabetes insipidus:</strong> Diabetes insipidus causes hypernatremia with dilute urine, opposite to this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pseudohyponatremia:</strong> Pseudohyponatremia is rare and associated with severe hyperlipidemia or hyperproteinemia, not applicable here.</span></p>",
    "correct_choice_id": 294157,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73807,
    "choices": [
      {
        "id": 294165,
        "text": "<p><span style=\"font-size:14.0pt;\">S. glucose &gt; 250 mg/dL</span></p>"
      },
      {
        "id": 294166,
        "text": "<p><span style=\"font-size:14.0pt;\">Arterial pH &lt; 7.3</span></p>"
      },
      {
        "id": 294167,
        "text": "<p><span style=\"font-size:14.0pt;\">Anion gap &gt; 12</span></p>"
      },
      {
        "id": 294168,
        "text": "<p><span style=\"font-size:14.0pt;\">S. Potassium &lt; 3.5 mEq/L</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">All of the following are criteria for diagnosis of DKA except:</span></p>",
    "unique_key": "Q3049975",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413708,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) S. Potassium &lt; 3.5 mEq/L</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">DKA is diagnosed with <strong>hyperglycemia, metabolic acidosis (pH &lt;7.3), and elevated anion gap</strong>. Serum potassium is usually normal or elevated initially due to insulin deficiency and acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. S. glucose &gt; 250 mg/Dl:</strong> Glucose &gt;250 mg/dL is a standard criterion for DKA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Arterial pH &lt; 7.3:</strong> pH &lt;7.3 indicates metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anion gap &gt; 12:</strong> Anion gap &gt;12 confirms high-anion-gap metabolic acidosis.</span></p>",
    "correct_choice_id": 294168,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67006,
    "choices": [
      {
        "id": 267157,
        "text": "<p><span style=\"font-size:14.0pt;\">Excessive caloric intake</span></p>"
      },
      {
        "id": 267158,
        "text": "<p><span style=\"font-size:14.0pt;\">Genetic polymorphisms in HLA genes</span></p>"
      },
      {
        "id": 267159,
        "text": "<p><span style=\"font-size:14.0pt;\">Pancreatic beta-cell amyloid deposition</span></p>"
      },
      {
        "id": 267160,
        "text": "<p><span style=\"font-size:14.0pt;\">Islet leukocytic infiltration&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old girl is brought to the emergency department due to confusion, abdominal pain, and vomiting for the past two days. Her parents report that she has been excessively thirsty and urinating frequently over the last few weeks. On examination, her vital signs are as follows: temperature 37.2\u00b0C (99\u00b0F), pulse 110/min, blood pressure 90/60 mm Hg, and respiratory rate 28/min. Laboratory investigations reveal the following:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Glucose 320 mg/dL</span></li><li><span style=\"font-size:14.0pt;\">Sodium 132 meq/l</span></li><li><span style=\"font-size:14.0pt;\">Potassium 5.2 meq/l</span></li><li><span style=\"font-size:14.0pt;\">Bicarbonate 12 meq/l</span></li><li><span style=\"font-size:14.0pt;\">Arterial pH 7.25</span></li><li><span style=\"font-size:14.0pt;\">Urinalysis: Positive for urine and ketones</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following factors most likely contributed to the development of this patient's condition?</span></p>",
    "unique_key": "Q4662758",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413709,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Islet leukocytic infiltration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has <strong>type 1 diabetes with DKA</strong>, where autoimmune <strong>islet leukocytic infiltration</strong> destroys beta cells, leading to insulin deficiency and ketosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;</strong>Excessive caloric intake does not directly cause DKA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;</strong>HLA polymorphisms increase susceptibility but are not the direct cause of acute DKA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;</strong>Beta-cell amyloid deposition is associated with type 2 diabetes, not type 1.</span></p>",
    "correct_choice_id": 267160,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73821,
    "choices": [
      {
        "id": 294221,
        "text": "<p><span style=\"font-size:14.0pt;\">Serum osmolality &gt; 350 mOsm/L&nbsp;</span></p>"
      },
      {
        "id": 294222,
        "text": "<p><span style=\"font-size:14.0pt;\">High mortality is associated</span></p>"
      },
      {
        "id": 294223,
        "text": "<p><span style=\"font-size:14.0pt;\">HAGMA is associated</span></p>"
      },
      {
        "id": 294224,
        "text": "<p><span style=\"font-size:14.0pt;\">Pre renal azotemia is seen&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">An elderly patient with type Il diabetes presents with altered sensorium. He has not been eating or drinking well for the past few weeks. There are no complaints of nausea or abdominal pain. His blood sugar level is 800 mg/dL. All of the following are true regarding this condition, except:</span></p>",
    "unique_key": "Q1555568",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413710,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) HAGMA is associated</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient likely has <strong>hyperosmolar hyperglycemic state (HHS)</strong>, characterized by extreme hyperglycemia, <strong>high serum osmolality, dehydration</strong>, and <strong>absence of significant ketosis or HAGMA</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Serum osmolality &gt; 350 mOsm/L:</strong> Serum osmolality is markedly elevated in HHS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. High mortality is associated:</strong> Mortality is higher in HHS compared to DKA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Pre-renal azotemia is seen:</strong> Pre-renal azotemia occurs due to severe dehydration.</span></p>",
    "correct_choice_id": 294223,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73836,
    "choices": [
      {
        "id": 294281,
        "text": "<p><span style=\"font-size:14.0pt;\">Mifepristone</span></p>"
      },
      {
        "id": 294282,
        "text": "<p><span style=\"font-size:14.0pt;\">Cabergoline</span></p>"
      },
      {
        "id": 294283,
        "text": "<p><span style=\"font-size:14.0pt;\">Bromocriptine</span></p>"
      },
      {
        "id": 294284,
        "text": "<p><span style=\"font-size:14.0pt;\">Metoclopramide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman, having lost her newborn, is producing breast milk, which risks developing into a breast abscess due to milk stasis and incomplete emptying. Which drug can prevent this complication?</span></p>",
    "unique_key": "Q6783617",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413711,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Cabergoline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cabergoline</strong>, a dopamine agonist, suppresses prolactin secretion and prevents lactation, reducing the risk of milk stasis and breast abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mifepristone:</strong> Mifepristone does not suppress lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cabergoline:</strong> Bromocriptine can suppress lactation but cabergoline is preferred due to fewer side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metoclopramide:</strong> Metoclopramide increases prolactin and promotes lactation.</span></p>",
    "correct_choice_id": 294282,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73839,
    "choices": [
      {
        "id": 294293,
        "text": "<p><span style=\"font-size:14.0pt;\">Head injury</span></p>"
      },
      {
        "id": 294294,
        "text": "<p><span style=\"font-size:14.0pt;\">Cardiogenic shock</span></p>"
      },
      {
        "id": 294295,
        "text": "<p><span style=\"font-size:14.0pt;\">Adrenal insufficiency&nbsp;</span></p>"
      },
      {
        "id": 294296,
        "text": "<p><span style=\"font-size:14.0pt;\">Myxedema coma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman presents to the ER with altered sensorium, non-pitting edema, hypothermia, bradycardia, and hypotension. What is the most likely diagnosis?&nbsp;</span></p>",
    "unique_key": "Q8997738",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413712,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Myxedema coma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has <strong>myxedema coma</strong>, indicated by severe hypothyroidism, altered mental status, hypothermia, bradycardia, hypotension, and non-pitting edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Head injury:</strong> Head injury does not explain hypothyroid features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cardiogenic shock:</strong> Cardiogenic shock lacks non-pitting edema and hypothermia typical of myxedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Adrenal insufficiency:</strong> Adrenal insufficiency presents with hypotension but without bradycardia and hypothermia specific to myxedema.</span></p>",
    "correct_choice_id": 294296,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73891,
    "choices": [
      {
        "id": 294501,
        "text": "<p><span style=\"font-size:14.0pt;\">Angiotensin II on vascular smooth muscle and Vasopressin via V1 receptor on vascular smooth muscle&nbsp;</span></p>"
      },
      {
        "id": 294502,
        "text": "<p><span style=\"font-size:14.0pt;\">Angiotensin Il on vascular smooth muscle and Vasopressin via V2 receptor on epithelial cells&nbsp;</span></p>"
      },
      {
        "id": 294503,
        "text": "<p><span style=\"font-size:14.0pt;\">Angiotensin II on epithelial cells and Vasopressin via V1 receptor on vascular smooth muscle&nbsp;</span></p>"
      },
      {
        "id": 294504,
        "text": "<p><span style=\"font-size:14.0pt;\">Angiotensin II on epithelial cells and Vasopressin via V2 receptor on epithelial cells&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following act via the IP3-DAG Messenger System?</span></p>",
    "unique_key": "Q7727054",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413713,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Angiotensin II on vascular smooth muscle and Vasopressin via V1 receptor on vascular smooth muscle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Angiotensin II (AT1 receptor) and vasopressin via V1 receptor</strong> activate the <strong>IP3-DAG pathway</strong>, leading to calcium release and smooth muscle contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Angiotensin II on vascular smooth muscle and Vasopressin via V2 receptor on epithelial cells:</strong> Vasopressin via V2 receptor works through cAMP, not IP3-DAG.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Angiotensin II on epithelial cells and Vasopressin via V1 receptor on vascular smooth muscle:</strong> Angiotensin II does not act on epithelial cells for IP3-DAG signaling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Angiotensin II on epithelial cells and Vasopressin via V2 receptor on epithelial cells:</strong> Both act on epithelial cells or V2 receptor via cAMP, not IP3-DAG.</span></p>",
    "correct_choice_id": 294501,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73953,
    "choices": [
      {
        "id": 294745,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulin resistance</span></p>"
      },
      {
        "id": 294746,
        "text": "<p><span style=\"font-size:14.0pt;\">Metabolic acidosis&nbsp;</span></p>"
      },
      {
        "id": 294747,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased androgen&nbsp;</span></p>"
      },
      {
        "id": 294748,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased cortisol&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with abdominal pain, nausea, and dizziness for the past few weeks. His investigations reveal hyponatremia and hyperkalemia. He also complains of skin changes as seen in the image below (A before 3 yrs; B,C,D at presentation). Which of the following is not a feature of this condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8ZQDhe7.png\" width=\"668\" height=\"631\"></span></p>",
    "unique_key": "Q8259285",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413714,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Insulin resistance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical images (C and D) show&nbsp;hyperpigmentation and thickened skin over the hands and palms, which is characteristic of&nbsp;acanthosis nigricans. This skin finding is most commonly associated with&nbsp;insulin resistance, seen in conditions such as type 2 diabetes mellitus and obesity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Metabolic acidosis:&nbsp;</strong>Does not cause characteristic acanthosis nigricans.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreased androgen:&nbsp;</strong>Not associated with the shown skin changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Decreased cortisol:&nbsp;</strong>Usually leads to diffuse hyperpigmentation (Addison's disease) but not the specific thickening seen here.</span></p>",
    "correct_choice_id": 294745,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74017,
    "choices": [
      {
        "id": 294997,
        "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
      },
      {
        "id": 294998,
        "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
      },
      {
        "id": 294999,
        "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
      },
      {
        "id": 295000,
        "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man comes to the physician for a follow-up examination. His blood pressure was 146/91 mm Hg at his appointment 1 month ago; subsequent home blood pressure measurements have ranged from 135/83 mm Hg to 156/96 mm Hg. His blood pressure today is 141/85 mm Hg. &nbsp;Pharmacotherapy with lisinopril is initiated. Administration of this drug is most likely to result in decreased activity of which of the following sections of a normal adrenal gland?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-10%20163048.jpg\" width=\"735\" height=\"410\"></span></p>",
    "unique_key": "Q4969516",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413715,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lisinopril is an&nbsp;ACE inhibitor&nbsp;that decreases aldosterone secretion by blocking the renin-angiotensin-aldosterone system. Aldosterone is produced in the&nbsp;zona glomerulosa, which corresponds to area&nbsp;B&nbsp;on the adrenal gland histology image. Reduced stimulation by angiotensin II results in decreased activity in this zone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A:</strong> Capsule, not hormone-producing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. C:</strong> Zona fasciculata\u2014mainly produces cortisol.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. D:</strong> Zona reticularis\u2014mainly produces androgens.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">E= adrenal medulla which produces Cathecholamines</span></p>",
    "correct_choice_id": 294998,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74038,
    "choices": [
      {
        "id": 295081,
        "text": "<p><span style=\"font-size:14.0pt;\">Zoledronate&nbsp;</span></p>"
      },
      {
        "id": 295082,
        "text": "<p><span style=\"font-size:14.0pt;\">Denosumab&nbsp;</span></p>"
      },
      {
        "id": 295083,
        "text": "<p><span style=\"font-size:14.0pt;\">Cinacalcet&nbsp;</span></p>"
      },
      {
        "id": 295084,
        "text": "<p><span style=\"font-size:14.0pt;\">Romosozumab</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">An 65-year-old female patient, with a recent history of a distal radius fracture, undergoes an assessment of bone mineral density. A DEXA scan shows a T-score of -2.6. Which of the following medications is not used for the management of this condition?</span></p>",
    "unique_key": "Q4701462",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413956,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cinacalcet</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cinacalcet is a calcimimetic used to treat hyperparathyroidism, not osteoporosis. The other agents are antiresorptive or anabolic medications used to improve bone density.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Zoledronate:</strong> Zoledronate is a bisphosphonate that reduces bone resorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Denosumab:</strong> Denosumab is a monoclonal antibody that inhibits RANKL, reducing osteoclast activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Romosozumab:</strong> Romosozumab is a sclerostin inhibitor that increases bone formation.</span></p>",
    "correct_choice_id": 295083,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35561,
    "choices": [
      {
        "id": 142051,
        "text": "<p><span style=\"font-size:14.0pt;\">Binding of activated receptors to DNA to modify transcription</span></p>"
      },
      {
        "id": 142052,
        "text": "<p><span style=\"font-size:14.0pt;\">Cyclic AMP-Protein kinase A pathway</span></p>"
      },
      {
        "id": 142053,
        "text": "<p><span style=\"font-size:14.0pt;\">Diacylglycerol-Protein kinase C pathway</span></p>"
      },
      {
        "id": 142054,
        "text": "<p><span style=\"font-size:14.0pt;\">JAK-STAT pathway</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 6-year-old girl is brought to the OPD for evaluation of short stature. Her parents have noticed that she bears little resemblance to her 2 older siblings. Other findings include low-set ears, a high arched palate, a webbed neck, and cubitus valgus. Chromosomal analysis reveals a 45, XO karyotype. The patient is started on a medication to improve growth and normalize her height. Which of the following intracellular pathways is stimulated by the medication used in this patient?</span></p>",
    "unique_key": "Q8585116",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413957,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) JAK-STAT pathway</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has Turner syndrome and is treated with growth hormone, which acts via the JAK-STAT pathway to stimulate IGF-1 production and promote growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Binding of activated receptors to DNA to modify transcription:</strong> DNA-binding receptors are typical of steroid hormones, not growth hormone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cyclic AMP-Protein kinase A pathway:</strong> cAMP-PKA pathway is used by hormones like ACTH or TSH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diacylglycerol-Protein kinase C pathway:</strong> DAG-PKC pathway is utilized by IP3/DAG signaling hormones.</span></p>",
    "correct_choice_id": 142054,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35549,
    "choices": [
      {
        "id": 142003,
        "text": "<p><span style=\"font-size:18px;\">Decreased conversion of T4 to T3</span></p>"
      },
      {
        "id": 142004,
        "text": "<p><span style=\"font-size:18px;\">Decreased thyroid iodine uptake</span></p>"
      },
      {
        "id": 142005,
        "text": "<p><span style=\"font-size:18px;\">Decreased TSH level</span></p>"
      },
      {
        "id": 142006,
        "text": "<p><span style=\"font-size:18px;\">Increased total T4 level</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 52-year-old, post-menopausal woman comes to the OPD for a follow-up appointment. Six months ago, the patient was evaluated for recurrent, brief episodes of excessive warmth and sweating, which were interfering with her usual activities. Thyroid hormone levels were normal, and the patient was subsequently diagnosed with menopausal hot flashes. Treatment with estrogen-containing hormone replacement therapy was begun with significant symptom improvement. Which of the following most likely occurred in this patient as a result of her medication use?</span></p>",
    "unique_key": "Q5188326",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413958,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Increased total T4 level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Estrogen therapy increases thyroxine-binding globulin (TBG), leading to an increase in total T4 levels, while free T4 remains normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decreased conversion of T4 to T3:</strong> Estrogen does not significantly affect T4 to T3 conversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Decreased thyroid iodine uptake:</strong> Iodine uptake by the thyroid is unaffected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreased TSH level:</strong> TSH levels remain largely unchanged if free T4 is normal.</span></p>",
    "correct_choice_id": 142006,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73917,
    "choices": [
      {
        "id": 294601,
        "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
      },
      {
        "id": 294602,
        "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
      },
      {
        "id": 294603,
        "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
      },
      {
        "id": 294604,
        "text": "<p><span style=\"font-size:14.0pt;\">E</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;64-year-old man comes to the OPD with fatigue. He has hypertension and poorly controlled diabetes complicated by nephropathy and peripheral neuropathy. His renal function has declined steadily over the last few years. &nbsp;On the graph below, area \"C\" shows the normal relationship between serum concentrations of free calcium and parathyroid hormone. Which of the following areas most likely represents this patient's current metabolic state?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-10%20134003.jpg\" width=\"501\" height=\"446\"></span></p>",
    "unique_key": "Q1842753",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413959,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a patient with&nbsp;chronic kidney disease&nbsp;and declining renal function, secondary hyperparathyroidism develops due to phosphate retention and decreased vitamin D activation, causing&nbsp;low serum calcium and high parathyroid hormone levels. On the graph, area A represents this state\u2014high parathyroid hormone with low serum calcium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. B:&nbsp;</strong>High calcium and PTH\u2014seen in primary hyperparathyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. C:&nbsp;</strong>Normal relationship\u2014healthy state.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. E:&nbsp;</strong>Low calcium and low PTH\u2014not typical in CKD with secondary hyperparathyroidism.</span></p>",
    "correct_choice_id": 294601,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73940,
    "choices": [
      {
        "id": 294693,
        "text": "<p><span style=\"font-size:14.0pt;\">Acute hemorrhage in the pituitary gland</span></p>"
      },
      {
        "id": 294694,
        "text": "<p><span style=\"font-size:14.0pt;\">Bleeding within the putamen</span></p>"
      },
      {
        "id": 294695,
        "text": "<p><span style=\"font-size:14.0pt;\">Dissection of the internal carotid artery</span></p>"
      },
      {
        "id": 294696,
        "text": "<p><span style=\"font-size:14.0pt;\">lschemic necrosis of the pituitary gland</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">50-year-old man is brought to the emergency department due to a severe, sudden-onset headache with loss of vision in bilateral temporal fields that started an hour ago. The patient reports that he has had mild headaches and decreased libido over the past 3 months.&nbsp; Shortly after being admitted to the hospital, he becomes acutely hypotensive and loses consciousness. Which of the following is most likely to be found on autopsy?</span></p>",
    "unique_key": "Q9656728",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413960,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Acute hemorrhage in the pituitary gland</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient likely had pituitary apoplexy, which presents as sudden headache, visual loss, hypotension, and hypopituitarism. Autopsy would reveal acute hemorrhage in the pituitary gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Bleeding within the putamen:</strong> Putaminal hemorrhage causes focal neurological deficits but not the endocrine features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Dissection of the internal carotid artery:</strong> Carotid dissection presents with stroke or Horner\u2019s syndrome, not hypopituitarism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Ischemic necrosis of the pituitary gland:</strong> Ischemic necrosis (Sheehan\u2019s syndrome) develops postpartum, not acutely in this male patient.</span></p>",
    "correct_choice_id": 294693,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92181,
    "choices": [
      {
        "id": 367040,
        "text": "<p><span style=\"font-size:14.0pt;\">Metformin is contraindicated in all stages of CKD</span></p>"
      },
      {
        "id": 367041,
        "text": "<p><span style=\"font-size:14.0pt;\">Pioglitazone is avoided as it is exclusively metabolized by kidneys</span></p>"
      },
      {
        "id": 367042,
        "text": "<p><span style=\"font-size:14.0pt;\">Glipizide can be used in renal disease</span></p>"
      },
      {
        "id": 367043,
        "text": "<p><span style=\"font-size:14.0pt;\">Linagliptin can be used only after dose reduction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old woman is diagnosed with type II diabetes mellitus. She has a history of chronic kidney disease. Which of the following statement is correct about the management of this patient?</span></p>",
    "unique_key": "Q3181021",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413961,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Glipizide can be used in renal disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Glipizide is metabolized by the liver and can be safely used in patients with renal disease, unlike some other sulfonylureas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Metformin is contraindicated in all stages of CKD:</strong> Metformin is contraindicated only in advanced CKD, not all stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pioglitazone is avoided as it is exclusively metabolized by kidneys:</strong> Pioglitazone is metabolized in the liver, not kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Linagliptin can be used only after dose reduction:</strong> Linagliptin does not require dose adjustment in CKD.</span></p>",
    "correct_choice_id": 367042,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73988,
    "choices": [
      {
        "id": 294885,
        "text": "<p><span style=\"font-size:14.0pt;\">Voglibose</span></p>"
      },
      {
        "id": 294886,
        "text": "<p><span style=\"font-size:14.0pt;\">Alogliptin</span></p>"
      },
      {
        "id": 294887,
        "text": "<p><span style=\"font-size:14.0pt;\">Pramlintide</span></p>"
      },
      {
        "id": 294888,
        "text": "<p><span style=\"font-size:14.0pt;\">Liraglutide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old female with diabetes mellitus has experienced a decrease in her HbA1c levels from 7.6 to 6.7 after starting a new oral medication. Laboratory tests show that she has high levels of GIP and GLP-1 and low levels of glucagon. Which of the following oral drugs was most likely administered to this patient?</span></p>",
    "unique_key": "Q4229136",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413962,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Alogliptin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Alogliptin is a DPP-4 inhibitor, which increases levels of incretins GIP and GLP-1, thereby reducing glucagon and lowering blood glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Voglibose:</strong> Voglibose inhibits carbohydrate absorption, not incretins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Pramlintide:</strong> Pramlintide is an amylin analog, not a DPP-4 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Liraglutide:</strong> Liraglutide is a GLP-1 receptor agonist, not an oral DPP-4 inhibitor.</span></p>",
    "correct_choice_id": 294886,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73992,
    "choices": [
      {
        "id": 294901,
        "text": "<p><span style=\"font-size:14.0pt;\">i, ii, iii, v</span></p>"
      },
      {
        "id": 294902,
        "text": "<p><span style=\"font-size:14.0pt;\">i, ii, iii, vi</span></p>"
      },
      {
        "id": 294903,
        "text": "<p><span style=\"font-size:14.0pt;\">i, ii, iii, v</span></p>"
      },
      {
        "id": 294904,
        "text": "<p><span style=\"font-size:14.0pt;\">i, ii, iv, v</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male presents with increased thirst and increased frequency and volume of urination. His random blood sugar was 205 mg/dl, what appropriate investigations should be done?&nbsp;</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:14.0pt;\">HbA1c</span></li><li><span style=\"font-size:14.0pt;\">Urine ACR&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Echocardiography</span></li><li><span style=\"font-size:14.0pt;\">Fundoscopy&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ECG&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Serum protein electrophoresis</span></li></ol>",
    "unique_key": "Q7457255",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413963,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;i, ii, iv, v</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For a patient presenting with hyperglycemia (random blood sugar 205 mg/dl), the appropriate investigations include:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>i)</strong> <strong>HbA1c:</strong> to assess long-term glycemic control.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>ii) Urine albumin-to-creatinine ratio (ACR):</strong> to screen for diabetic nephropathy.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>iv) Fundoscopy:</strong> to evaluate for diabetic retinopathy.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>v) ECG:</strong> to assess for cardiovascular risk factors common in diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>iii) Echocardiography:</strong> not routinely indicated initially unless cardiac symptoms are present.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>vi) Serum protein electrophoresis:</strong> unrelated to diabetes evaluation.</span></p>",
    "correct_choice_id": 294904,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 70034,
    "choices": [
      {
        "id": 279209,
        "text": "<p><span style=\"font-size:14.0pt;\">GH low, IGF-1 low, adenoma size low&nbsp;</span></p>"
      },
      {
        "id": 279210,
        "text": "<p><span style=\"font-size:14.0pt;\">GH low, IGF-1 low, adenoma size unchanged</span></p>"
      },
      {
        "id": 279211,
        "text": "<p><span style=\"font-size:14.0pt;\">GH low, IGF-1 unchanged, adenoma size low&nbsp;</span></p>"
      },
      {
        "id": 279212,
        "text": "<p><span style=\"font-size:14.0pt;\">GH unchanged, IGF-1 low, adenoma size unchanged</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man comes to the OPD following transsphenoidal resection of a growth hormone secreting pituitary adenoma. Three months ago, the patient was diagnosed with acromegaly. MRI of the pituitary showed a 14 mm sellar mass pressing on the optic chiasm and extending into the right cavernous sinus. The surgeon was able to only partially resect the pituitary mass because of the extension into the right cavernous sinus. Medical therapy for acromegaly with octreotide is planned. Which of the following changes are likely to occur following octreotide treatment in this patient?</span></p>",
    "unique_key": "Q4753564",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413964,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) GH low, IGF-1 low, adenoma size low&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Octreotide is a somatostatin analogue that suppresses growth hormone (GH) secretion from pituitary adenomas. This leads to a decrease in both GH and insulin-like growth factor 1 (IGF-1) levels. Additionally, octreotide often causes tumor shrinkage, resulting in decreased adenoma size.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. GH low, IGF-1 low, adenoma size unchanged:&nbsp;</strong>Adenoma size usually decreases with octreotide treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. GH low, IGF-1 unchanged, adenoma size low:</strong> IGF-1 levels typically decrease along with GH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. GH unchanged, IGF-1 low, adenoma size unchanged</strong>: GH levels decrease first; unchanged GH with low IGF-1 is unlikely.</span></p>",
    "correct_choice_id": 279209,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 61524,
    "choices": [
      {
        "id": 245373,
        "text": "<p><span style=\"font-size:14.0pt;\">ACTH low, Aldosterone low, Cortisol low</span></p>"
      },
      {
        "id": 245374,
        "text": "<p><span style=\"font-size:14.0pt;\">ACTH low, Aldosterone high, Cortisol low</span></p>"
      },
      {
        "id": 245375,
        "text": "<p><span style=\"font-size:14.0pt;\">ACTH high, Aldosterone normal, Cortisol low</span></p>"
      },
      {
        "id": 245376,
        "text": "<p><span style=\"font-size:14.0pt;\">ACTH low, Aldosterone normal, Cortisol low</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Two days after vaginal delivery of a healthy newborn at term, a 32-year-old woman, gravida 2, para 2, is unable to breastfeed. Her labor was complicated by antepartum hemorrhage and she received two units of packed red blood cells. Her pulse is 99/min and blood pressure is 90/55 mm Hg. Further evaluation of this patient is most likely to show which of the following sets of serum findings?</span></p>",
    "unique_key": "Q5960357",
    "question_audio": null,
    "question_video": null,
    "map_id": 33413965,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) ACTH low, Aldosterone normal, Cortisol low</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient presents with inability to breastfeed two days postpartum, hypotension, and a history of significant antepartum hemorrhage with blood transfusions, suggesting postpartum hypopituitarism (Sheehan syndrome).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In Sheehan syndrome, ischemic necrosis of the pituitary leads to decreased secretion of anterior pituitary hormones, including ACTH, resulting in secondary adrenal insufficiency with low cortisol levels. Aldosterone secretion is typically preserved because it is regulated mainly by the renin-angiotensin system, not ACTH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore, the most likely serum findings are: ACTH low, Aldosterone normal, Cortisol low</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ACTH low, Aldosterone low, Cortisol low:&nbsp;</strong>Aldosterone is usually normal because it is regulated independently of ACTH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. ACTH low, Aldosterone high, Cortisol low:&nbsp;</strong>Aldosterone is unlikely to be high in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. ACTH high, Aldosterone normal, Cortisol low:&nbsp;</strong>ACTH would be low due to pituitary failure, not high.</span></p>",
    "correct_choice_id": 245376,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 42457,
    "choices": [
      {
        "id": 169507,
        "text": "<p><span style=\"font-size:14.0pt;\">Bromocriptine \u2013 Treatment of precocious puberty</span></p>"
      },
      {
        "id": 169508,
        "text": "<p><span style=\"font-size:14.0pt;\">Octreotide \u2013 Treatment of diarrhea associated with vasoactive intestinal peptide tumors.</span></p>"
      },
      {
        "id": 169509,
        "text": "<p><span style=\"font-size:14.0pt;\">Desmopressin \u2013 Treatment of diabetes insipidus</span></p>"
      },
      {
        "id": 169510,
        "text": "<p><span style=\"font-size:14.0pt;\">Leuprolide \u2013 Treatment of infertility</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following pairs of drugs and its indications is matched incorrectly?</span></p>",
    "unique_key": "Q5049888",
    "question_audio": null,
    "question_video": null,
    "map_id": 33414975,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Bromocriptine \u2013 Treatment of precocious puberty</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bromocriptine is primarily used for hyperprolactinemia and Parkinson\u2019s disease, not precocious puberty.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Octreotide \u2013 Treatment of diarrhea associated with vasoactive intestinal peptide tumors:</strong> Octreotide is correctly indicated for VIPoma-associated diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Desmopressin \u2013 Treatment of diabetes insipidus:</strong> Desmopressin treats central diabetes insipidus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Leuprolide \u2013 Treatment of infertility:</strong> Leuprolide is used in assisted reproduction for infertility management.</span></p>",
    "correct_choice_id": 169507,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25681,
    "choices": [
      {
        "id": 102674,
        "text": "<p><span style=\"font-size:18px;\">Central Diabetes insipidus</span></p>"
      },
      {
        "id": 102675,
        "text": "<p><span style=\"font-size:18px;\">Nephrogenic DI</span></p>"
      },
      {
        "id": 102676,
        "text": "<p><span style=\"font-size:18px;\">Primary polydipsia</span></p>"
      },
      {
        "id": 102677,
        "text": "<p><span style=\"font-size:18px;\">Syndrome of inappropriate antidiuretic hormone</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">53-year-old man comes to the physician complaining of increased urinary frequency for the past 4 weeks. He has no burning with urination, urgency, or difficulty initiating urination. He wakes up several times at night to urinate. His mouth feels dry all the time and he drinks fluids almost every hour to alleviate his thirst. The patient's medications include hydrochlorothiazide and amlodipine for hypertension. His sister was diagnosed with diabetes mellitus at a young age. His blood pressure is 120/76 mm Hg, pulse is 85/min, and respirations are 15/min. His body mass index is 32 kg/m\u00b2. Laboratory results are as follows:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:18px;\">Blood glucose-93 mg/dL</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Serum sodium-150 mEg:L</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Serum potassium-4.1 mEq/L</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Bicarbonate-24 mEq/L</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Blood urea nitrogen-21 mg/dL</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Serum creatinine-1.1 mg/dL</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Serum uric acid-10.1 mg/dL (N- 3.5-7.2 mg/dL)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Serum osmolality-314 mOsm/kg (N- 275 to 295 mOsm/kg)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Urine osmolality-124 mOsm/kg (N-500 - 800 mOsm/kg)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Which of the following is most consistent with this patient's findings?</span></p>",
    "unique_key": "Q2538973",
    "question_audio": null,
    "question_video": null,
    "map_id": 33414976,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)</strong></span><strong>&nbsp;</strong><span style=\"font-size:14.0pt;\"><strong>Central Diabetes insipidus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has central diabetes insipidus, indicated by hypernatremia, high serum osmolality, and inappropriately dilute urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Nephrogenic DI:</strong> Nephrogenic DI shows resistance to ADH, often due to drugs or renal disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Primary polydipsia:</strong> Primary polydipsia presents with hyponatremia and low serum osmolality.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Syndrome of inappropriate antidiuretic hormone:</strong> SIADH presents with hyponatremia and concentrated urine.</span></p>",
    "correct_choice_id": 102674,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29202,
    "choices": [
      {
        "id": 116714,
        "text": "<p><span style=\"font-size:14.0pt;\">Acetylcholine</span></p>"
      },
      {
        "id": 116715,
        "text": "<p><span style=\"font-size:14.0pt;\">ACTH</span></p>"
      },
      {
        "id": 116716,
        "text": "<p><span style=\"font-size:14.0pt;\">Angiotensin ll</span></p>"
      },
      {
        "id": 116717,
        "text": "<p><span style=\"font-size:14.0pt;\">Epinephrine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">The cells marked in the image of adrenal biopsy are directly activated by?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture22.jpg\" alt=\"\" width=\"300\" height=\"329\"></span></p>",
    "unique_key": "Q5867752",
    "question_audio": null,
    "question_video": null,
    "map_id": 33414977,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Acetylcholine&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image shows the&nbsp;adrenal medulla, with the arrow indicating&nbsp;chromaffin cells. These cells are&nbsp;directly activated by acetylcholine&nbsp;released from preganglionic sympathetic fibers, leading to secretion of catecholamines (epinephrine and norepinephrine).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;ACTH:&nbsp;</strong>Stimulates the adrenal cortex, not the medulla.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Angiotensin II:&nbsp;</strong>Stimulates aldosterone in the zona glomerulosa of the cortex, not adrenal<strong> medulla.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Epinephrine:&nbsp;</strong>Is secreted by the adrenal medulla, but does not activate chromaffin cells.</span></p>",
    "correct_choice_id": 116714,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29242,
    "choices": [
      {
        "id": 116874,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture69.jpg\" alt=\"\" width=\"300\" height=\"326\"></p>"
      },
      {
        "id": 116875,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture70.jpg\" alt=\"\" width=\"300\" height=\"330\"></p>"
      },
      {
        "id": 116876,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture72.jpg\" alt=\"\" width=\"300\" height=\"237\"></p>"
      },
      {
        "id": 116877,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture73.jpg\" alt=\"\" width=\"300\" height=\"202\"></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">51-year-old woman comes to the OPD due to progressively worsening fatigue, weight gain, and constipation for the past 6 months. Physical examination shows mild, diffuse enlargement of the thyroid gland.&nbsp; Biopsy of this patient's thyroid is most likely to show which of the following findings?</span></p>",
    "unique_key": "Q4964134",
    "question_audio": null,
    "question_video": null,
    "map_id": 33414978,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KVpKT9z.png\" width=\"223\" height=\"241\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patients condition is likely suggestive of Hashimoto thyroiditis denoted by option A and symptoms of hypothyroidism such WEIGHT GAIN , CONSTIPATION Ahave been mentioned in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> Is Medullary CA thyroid</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. Suggestive of papillary Ca thyroid</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> Suggests Amyloidosis inside thyroid</span></p>",
    "correct_choice_id": 116874,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92184,
    "choices": [
      {
        "id": 367052,
        "text": "<p><span style=\"font-size:14.0pt;\">2-3 L of normal saline over 1-3 hours</span></p>"
      },
      {
        "id": 367053,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulin infusion at 0.1 units/kg/hour</span></p>"
      },
      {
        "id": 367054,
        "text": "<p><span style=\"font-size:14.0pt;\">Arterial blood gas</span></p>"
      },
      {
        "id": 367055,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulin bolus of 0.1 units/kg given IV</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old child who is known to have type 1 diabetes mellitus presents with confusion and drowsiness. Her mother says that she seems to be breathing very fast. On examination, mucous membranes are dry and blood pressure is 70/50 mm Hg. Random blood glucose is 415 mg/dl and urine ketones are 4+. What is the next best step in management?</span></p>",
    "unique_key": "Q5550943",
    "question_audio": null,
    "question_video": null,
    "map_id": 33414979,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 2-3 L of normal saline over 1-3 hours</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Initial management of <strong>diabetic ketoacidosis with shock</strong> requires rapid <strong>fluid resuscitation with normal saline</strong> to restore perfusion before insulin therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Insulin infusion at 0.1 units/kg/hour:</strong> Insulin infusion is started after initial fluid resuscitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Arterial blood gas:</strong> ABG is useful but not the immediate life-saving step.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Insulin bolus of 0.1 units/kg given IV:</strong> Insulin bolus is not recommended in pediatric DKA due to risk of cerebral edema.</span></p>",
    "correct_choice_id": 367052,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29258,
    "choices": [
      {
        "id": 116938,
        "text": "<p><span style=\"font-size:14.0pt;\">Desmopressin</span></p>"
      },
      {
        "id": 116939,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydrochlorothiazide</span></p>"
      },
      {
        "id": 116940,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydrocortisone</span></p>"
      },
      {
        "id": 116941,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 6-week-old term boy is brought to the OPD due to increased fussiness and poor weight gain. The patient has several wet diapers per day. His anterior fontanelle is flat and mucous membranes are dry. Laboratory results include the following:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:18px;\">Sodium: 148 mEq/L</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Potassium: 3.5 mEq/L</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Antidiuretic hormone: increased</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Urinalysis shows a specific gravity of 1.002. Which of the following is the most appropriate treatment for this patient's condition?</span></p>",
    "unique_key": "Q3695588",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416132,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hydrochlorothiazide</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has <strong>nephrogenic diabetes insipidus</strong>, indicated by hypernatremia, dilute urine, and elevated ADH. <strong>Hydrochlorothiazide</strong> reduces urine output by inducing mild volume depletion and enhancing proximal tubular water reabsorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Desmopressin:</strong> Desmopressin is ineffective in nephrogenic DI.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hydrocortisone:</strong> Hydrocortisone is not indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Insulin:</strong> Insulin is unrelated to this condition.</span></p>",
    "correct_choice_id": 116939,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35559,
    "choices": [
      {
        "id": 142043,
        "text": "<p><span style=\"font-size:14.0pt;\">24-Hour UFC</span></p>"
      },
      {
        "id": 142044,
        "text": "<p><span style=\"font-size:14.0pt;\">S. ACTH</span></p>"
      },
      {
        "id": 142045,
        "text": "<p><span style=\"font-size:14.0pt;\">Fasting GH levels</span></p>"
      },
      {
        "id": 142046,
        "text": "<p><span style=\"font-size:14.0pt;\">S. IGF-1</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 45-year-old man reports coarsening of his facial features over several years. In addition, he reports low libido and decreased energy. Physical examination shows frontal bossing and enlarges hands. Which of the following screening tests should be ordered?</span></p>",
    "unique_key": "Q1884595",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416133,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) S. IGF-1</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Serum IGF-1</strong> is the preferred screening test for <strong>acromegaly</strong>, reflecting chronic GH excess.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 24-Hour UFC:</strong> 24-hour UFC screens for Cushing\u2019s syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. S. ACTH:</strong> Serum ACTH measures adrenal function, not GH excess.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fasting GH levels:</strong> Fasting GH levels fluctuate and are unreliable for screening.</span></p>",
    "correct_choice_id": 142046,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35565,
    "choices": [
      {
        "id": 142067,
        "text": "<p><span style=\"font-size:14.0pt;\">Low calcium</span></p>"
      },
      {
        "id": 142068,
        "text": "<p><span style=\"font-size:14.0pt;\">Low PTH</span></p>"
      },
      {
        "id": 142069,
        "text": "<p><span style=\"font-size:14.0pt;\">Short 4th and 5th metacarpals</span></p>"
      },
      {
        "id": 142070,
        "text": "<p><span style=\"font-size:14.0pt;\">Short stature</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Which of the following is not associated with pseudohypoparathyroidism?</span></p>",
    "unique_key": "Q5766288",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416134,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong></span><strong>&nbsp;</strong><span style=\"font-size:14.0pt;\"><strong>Low PTH</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pseudohypoparathyroidism</strong> features <strong>resistance to PTH</strong>, so <strong>PTH levels are elevated</strong>, not low.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Low calcium:</strong> Low calcium occurs due to end-organ resistance to PTH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Short 4th and 5th metacarpals:</strong> Short 4th and 5th metacarpals are a classic finding (Albright hereditary osteodystrophy).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Short stature:</strong> Short stature is commonly seen in this condition.</span></p>",
    "correct_choice_id": 142068,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35588,
    "choices": [
      {
        "id": 142159,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulin-like growth factor-1</span></p>"
      },
      {
        "id": 142160,
        "text": "<p><span style=\"font-size:14.0pt;\">Glucagon-like peptide-1</span></p>"
      },
      {
        "id": 142161,
        "text": "<p><span style=\"font-size:14.0pt;\">Somatostatin&nbsp;</span></p>"
      },
      {
        "id": 142162,
        "text": "<p><span style=\"font-size:14.0pt;\">Secretin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Researchers measure the serum insulin levels of healthy volunteers after equivalent loads of oral (dotted line) and intravenous glucose (solid line). The following curves are observed. Which of the following endogenous substances best explains the difference between the curves?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/picture15_OhwOgHr.jpg\" alt=\"\" width=\"300\" height=\"282\"></span></p>",
    "unique_key": "Q8546820",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416135,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Glucagon-like peptide-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The graph shows&nbsp;higher insulin secretion after oral glucose (dotted line)&nbsp;compared to intravenous glucose (solid line). This difference is explained by the&nbsp;incretin effect, primarily due to&nbsp;glucagon-like peptide-1 (GLP-1), an endogenous hormone released from the intestine after oral glucose that stimulates insulin secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Insulin-like growth factor-1:&nbsp;</strong>Not directly involved in acute insulin secretion after glucose intake.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Somatostatin:&nbsp;</strong>Inhibits insulin secretion, would not account for the increased oral response.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Secretin:&nbsp;</strong>Regulates pancreatic secretion but does not significantly affect insulin release in response to glucose.</span></p>",
    "correct_choice_id": 142160,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57463,
    "choices": [
      {
        "id": 229225,
        "text": "<p><span style=\"font-size:14.0pt;\">Receptor tyrosine kinase</span></p>"
      },
      {
        "id": 229226,
        "text": "<p><span style=\"font-size:14.0pt;\">Cytokine receptor</span></p>"
      },
      {
        "id": 229227,
        "text": "<p><span style=\"font-size:14.0pt;\">Antiapoptotic molecule</span></p>"
      },
      {
        "id": 229228,
        "text": "<p><span style=\"font-size:14.0pt;\">Nonreceptor tyrosine kinase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old man comes to the physician because of blurry vision and fatigue for 2 months. During this period, he has also had occasional bleeding from his gums after brushing his teeth. One month ago, he was diagnosed with deep vein thrombosis after returning from an overseas business meeting. His pulse is 118/min, respirations are 19/min, and blood pressure is 149/91 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 97%. Examination shows bluish discoloration of the lips. The tip of the spleen is palpable 1 cm below the left costal margin. Sensory examination of the hands shows paraesthesia. Hemoglobin concentration is 18 g/dL, haematocrit is 65%, leukocytes are 15,000/uL, and platelets are 470,000/uL. His serum erythropoietin concentration is decreased. Activation of which of the following is the most likely underlying cause of this patient's condition?</span></p>",
    "unique_key": "Q6506404",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416136,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;Nonreceptor tyrosine kinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">JAK2 is a nonreceptor tyrosine kinase mutated in polycythemia vera, causing constitutive activation of signaling pathways that drive uncontrolled proliferation of hematopoietic stem cells independent of erythropoietin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Receptor tyrosine kinase:&nbsp;</strong>These are membrane receptors with intrinsic kinase activity involved in other signaling pathways, not typically mutated in polycythemia vera.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cytokine receptor:&nbsp;</strong>Cytokine receptors lack intrinsic kinase activity and function by associating with kinases like JAK2, so the receptor itself is not the active molecule here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Antiapoptotic molecule:&nbsp;</strong>Polycythemia vera results from increased cell proliferation signaling rather than primary defects in apoptosis regulation.</span></p>",
    "correct_choice_id": 229228,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57472,
    "choices": [
      {
        "id": 229261,
        "text": "<p><span style=\"font-size:14.0pt;\">ACTH-producing growth in the pituitary gland</span></p>"
      },
      {
        "id": 229262,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased urinary excretion of metanephrines</span></p>"
      },
      {
        "id": 229263,
        "text": "<p><span style=\"font-size:14.0pt;\">Pleomorphic modified smooth muscle cells in the renal cortex</span></p>"
      },
      {
        "id": 229264,
        "text": "<p><span style=\"font-size:14.0pt;\">Involution of zona glomerulosa of the adrenal gland</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old girl comes to the physician because of a 2-month history of progressive fatigue and weakness. She also reports recurrent headaches for 2 years, which have increased in severity and frequency. Her blood pressure is 185/95 mm Hg. Serum studies show a morning renin activity of 130 ng/mL per hour (N=1-4), a morning aldosterone concentration of 60 ng/dL (N=5-30), and a potassium concentration of 2.9 mEq/L. Further evaluation is most likely to show which of the following?</span></p>",
    "unique_key": "Q2442546",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416137,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pleomorphic modified smooth muscle cells in the renal cortex</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pleomorphic modified smooth muscle cells are characteristic of fibromuscular dysplasia, a common cause of renovascular hypertension in young females. This leads to renal artery stenosis, resulting in increased renin and aldosterone secretion, causing hypertension and hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ACTH-producing growth in the pituitary gland:</strong> Causes Cushing disease, leading to cortisol excess, not elevated renin or aldosterone levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased urinary excretion of metanephrines:</strong> Indicative of pheochromocytoma, which causes episodic hypertension without significant renin or aldosterone elevation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Involution of zona glomerulosa of the adrenal gland:</strong> Would decrease aldosterone production, causing hypotension and hyperkalemia, not hypertension or hypokalemia.</span></p>",
    "correct_choice_id": 229263,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57484,
    "choices": [
      {
        "id": 229309,
        "text": "<p><span style=\"font-size:14.0pt;\">Nelson syndrome&nbsp;</span></p>"
      },
      {
        "id": 229310,
        "text": "<p><span style=\"font-size:14.0pt;\">Sheehan syndrome&nbsp;</span></p>"
      },
      {
        "id": 229311,
        "text": "<p><span style=\"font-size:14.0pt;\">Conn's syndrome&nbsp;</span></p>"
      },
      {
        "id": 229312,
        "text": "<p><span style=\"font-size:14.0pt;\">Addison's disease&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A woman comes with complaints of hyperpigmentation of her palms after an adrenalectomy. She also has new onset vision deficits. What is the likely diagnosis?</span></p>",
    "unique_key": "Q1050122",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416138,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Nelson syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nelson syndrome occurs after bilateral adrenalectomy due to loss of cortisol feedback inhibition on the pituitary. This leads to enlargement of an existing ACTH-secreting pituitary adenoma, resulting in high ACTH levels and hyperpigmentation along with possible mass effects causing vision deficits.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Sheehan syndrome:&nbsp;</strong>Caused by postpartum pituitary infarction leading to hypopituitarism, typically without hyperpigmentation or vision loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Conn's syndrome:&nbsp;</strong>Characterized by primary hyperaldosteronism causing hypertension and hypokalemia, not hyperpigmentation or vision problems.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Addison's disease:&nbsp;</strong>Primary adrenal insufficiency causing hyperpigmentation but not typically associated with vision deficits or occurring after adrenalectomy.</span></p>",
    "correct_choice_id": 229309,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57487,
    "choices": [
      {
        "id": 229321,
        "text": "<p><span style=\"font-size:14.0pt;\">PTH increased, vit D decreased, Ca increased, Po<sub>4</sub> decreased</span></p>"
      },
      {
        "id": 229322,
        "text": "<p><span style=\"font-size:14.0pt;\">PTH increased, vit D decreased, Ca decreased, Po<sub>4</sub> increased</span></p>"
      },
      {
        "id": 229323,
        "text": "<p><span style=\"font-size:14.0pt;\">PTH decreased, vit D increased, Ca increased, Po<sub>4</sub> decreased</span></p>"
      },
      {
        "id": 229324,
        "text": "<p><span style=\"font-size:14.0pt;\">PTH decreased, vit D decreased, Ca decreased, Po<sub>4</sub> increased</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man comes to the physician for a follow-up examination. He has type 2 diabetes mellitus, hypertension, and chronic kidney disease. Medications include insulin, metoprolol, and atorvastatin. Physical examination shows pitting edema of both ankles. Serum creatinine concentration is 4.5 mg/dl. Which of the following sets of serum findings is most likely in this patient?</span></p>",
    "unique_key": "Q4986542",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416139,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) PTH increased, vit D decreased, Ca decreased, Po4 increased</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In chronic kidney disease, decreased renal conversion of vitamin D reduces calcium absorption, leading to hypocalcemia. Low calcium and phosphate retention stimulate parathyroid hormone (PTH) secretion, causing secondary hyperparathyroidism with increased PTH, low vitamin D, low calcium, and high phosphate levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. PTH increased, vit D decreased, Ca increased, Po4 decreased:</strong> Incorrect because calcium is usually decreased, and phosphate is increased due to reduced excretion in CKD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. PTH decreased, vit D increased, Ca increased, Po4 decreased:&nbsp;</strong>Incorrect; PTH is typically elevated in CKD to compensate for hypocalcemia, while vitamin D levels are decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. PTH decreased, vit D decreased, Ca decreased, Po4 increased</strong>: Incorrect because decreased PTH does not occur in CKD; PTH is usually elevated in response to hypocalcemia and hyperphosphatemia.</span></p>",
    "correct_choice_id": 229322,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57523,
    "choices": [
      {
        "id": 229465,
        "text": "<p><span style=\"font-size:14.0pt;\">Pioglitazone</span></p>"
      },
      {
        "id": 229466,
        "text": "<p><span style=\"font-size:14.0pt;\">Pramlintide</span></p>"
      },
      {
        "id": 229467,
        "text": "<p><span style=\"font-size:14.0pt;\">Glimepiride</span></p>"
      },
      {
        "id": 229468,
        "text": "<p><span style=\"font-size:14.0pt;\">Metformin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following anti-diabetic drug is associated with unexplained diarrhea?</span></p>",
    "unique_key": "Q8787150",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416140,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Metformin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Metformin is commonly associated with gastrointestinal side effects, including unexplained diarrhea, due to its effects on intestinal absorption and motility. This is a well-known adverse effect often limiting its tolerability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pioglitazone:&nbsp;</strong>Primarily causes fluid retention and weight gain, with diarrhea being uncommon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pramlintide:&nbsp;</strong>May cause nausea and vomiting, but diarrhea is not a typical side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glimepiride:&nbsp;</strong>Sulfonylureas like glimepiride commonly cause hypoglycemia and weight gain, not diarrhea.</span></p>",
    "correct_choice_id": 229468,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57448,
    "choices": [
      {
        "id": 229165,
        "text": "<p><span style=\"font-size:18px;\">Tesamorelin</span></p>"
      },
      {
        "id": 229166,
        "text": "<p><span style=\"font-size:18px;\">Sermorelin</span></p>"
      },
      {
        "id": 229167,
        "text": "<p><span style=\"font-size:18px;\">Somatropin</span></p>"
      },
      {
        "id": 229168,
        "text": "<p><span style=\"font-size:18px;\">Pegvisomant</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following growth hormone analogue that is not used for treatment of GH deficiency but is used in the treatment of HIV-associated lipodystrophy? (NEET PG 2024)</span></p>",
    "unique_key": "Q6836576",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416141,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Tesamorelin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that is specifically used in the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal distribution of body fat in patients with HIV. Tesamorelin reduces visceral adipose tissue and improves the body composition of individuals with this condition. Unlike other growth hormone analogues, Tesamorelin is not primarily used for treating growth hormone deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Sermorelin</strong>: Sermorelin is a synthetic analogue of GHRH used to diagnose and treat growth hormone deficiency. It is not indicated for the treatment of HIV-associated lipodystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Somatropin</strong>: Somatropin is a recombinant form of human growth hormone used to treat growth hormone deficiencies. It is not used for the treatment of HIV-associated lipodystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Pegvisomant</strong>: Pegvisomant is a growth hormone receptor antagonist used in the treatment of acromegaly. It is not used for HIV-associated lipodystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Tesamorelin is a growth hormone-releasing hormone analogue used specifically for the treatment of HIV-associated lipodystrophy, distinguishing it from other growth hormone analogues that are used for treating growth hormone deficiencies.</span></p>",
    "correct_choice_id": 229165,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67014,
    "choices": [
      {
        "id": 267189,
        "text": "<p><span style=\"font-size:14.0pt;\">Somatropin</span></p>"
      },
      {
        "id": 267190,
        "text": "<p><span style=\"font-size:14.0pt;\">Octreotide</span></p>"
      },
      {
        "id": 267191,
        "text": "<p><span style=\"font-size:14.0pt;\">Mecasermin</span></p>"
      },
      {
        "id": 267192,
        "text": "<p><span style=\"font-size:14.0pt;\">Oxandrolone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">An 8-year-old boy was referred to a pediatric endocrinologist because of growth retardation. Lab tests showed increased serum growth hormone levels but very low serum levels of insulin-like growth factor 1 (IGF-1). Further exams led to the diagnosis of Laron dwarfism. Which of the following drugs would be most appropriate for this boy?</span></p>",
    "unique_key": "Q6696588",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416482,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mecasermin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mecasermin is recombinant IGF-1 and is the treatment of choice for Laron dwarfism, where GH receptor defects cause low IGF-1 despite high GH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Somatropin:&nbsp;</strong>Ineffective as GH receptors are defective in Laron dwarfism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Octreotide:&nbsp;</strong>A somatostatin analogue that inhibits GH secretion, not useful here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Oxandrolone:&nbsp;</strong>An anabolic steroid not used for treating growth hormone receptor defects.</span></p>",
    "correct_choice_id": 267191,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67031,
    "choices": [
      {
        "id": 267257,
        "text": "<p><span style=\"font-size:14.0pt;\">Pituitary</span></p>"
      },
      {
        "id": 267258,
        "text": "<p><span style=\"font-size:14.0pt;\">Placenta&nbsp;</span></p>"
      },
      {
        "id": 267259,
        "text": "<p><span style=\"font-size:14.0pt;\">Salivary gland&nbsp;</span></p>"
      },
      {
        "id": 267260,
        "text": "<p><span style=\"font-size:14.0pt;\">Thyroid</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Sodium iodide symport is present in all of the following except:&nbsp;</span></p>",
    "unique_key": "Q4908611",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416483,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pituitary</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The sodium iodide symporter is responsible for iodide uptake in thyroid, salivary gland, and placenta but is not present in the pituitary gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Placenta:&nbsp;</strong>Has sodium iodide symporter to actively transport iodide to the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Salivary gland:&nbsp;</strong>Expresses the symporter for iodide concentration in saliva.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Thyroid:&nbsp;</strong>The primary site of sodium iodide symporter expression for thyroid hormone synthesis.</span></p>",
    "correct_choice_id": 267257,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67050,
    "choices": [
      {
        "id": 267333,
        "text": "<p><span style=\"font-size:14.0pt;\">Adrenal pheochromocytoma</span></p>"
      },
      {
        "id": 267334,
        "text": "<p><span style=\"font-size:14.0pt;\">Endometrial carcinoma</span></p>"
      },
      {
        "id": 267335,
        "text": "<p><span style=\"font-size:14.0pt;\">Pituitary adenoma</span></p>"
      },
      {
        "id": 267336,
        "text": "<p><span style=\"font-size:14.0pt;\">Thyroid medullary carcinoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old man developed sudden severe abdominal pain. On physical examination, he had marked abdominal tenderness and guarding. Laboratory studies showed calcium-12.2 mg/dL; phosphorus-2.6 mg/ dL; creatinine, 1.1 mg/dL; and parathyroid hormone-62 pg/mL (normal: 9-60 pg/mL). During surgery, four enlarged parathyroid glands were found and excised, with re-implantation of one half of one gland. After the surgery, his calcium concentration returned to normal. Three years later, he had an episode of upper gastrointestinal hemorrhage. An endoscopy and biopsy specimen showed multiple benign gastric ulcerations. Abdominal MRI indicated multiple 1- to 2-cm mass lesions in the pancreas. Which of the following additional neoplasm lesions is he most likely to have?</span></p>",
    "unique_key": "Q9331774",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416484,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pituitary adenoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient likely has Multiple Endocrine Neoplasia type 1 (MEN1), characterized by parathyroid hyperplasia, pancreatic neuroendocrine tumors, and pituitary adenomas. Pituitary adenoma is the common third tumor.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adrenal pheochromocytoma:&nbsp;</strong>Typical of MEN2, not MEN1.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Endometrial carcinoma:&nbsp;</strong>Not associated with MEN syndromes.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Thyroid medullary carcinoma:&nbsp;</strong>Characteristic of MEN2, not MEN1.&nbsp;</span></p>",
    "correct_choice_id": 267335,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67154,
    "choices": [
      {
        "id": 267741,
        "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune +ve Normoglycemic presymptomatic</span></p>"
      },
      {
        "id": 267742,
        "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune +ve dysglycemic symptomatic</span></p>"
      },
      {
        "id": 267743,
        "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune -ve Normoglycemic presymptomatic</span></p>"
      },
      {
        "id": 267744,
        "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune -ve dysglycemic presymptomatic</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">In Type 1 Diabetes Mellitus, what is the feature of stage 3 beta cell destruction?&nbsp;</span></p>",
    "unique_key": "Q6202791",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416485,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Autoimmune +ve dysglycemic symptomatic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Stage 3 represents the clinical onset of Type 1 DM with autoimmune destruction of beta cells, causing dysglycemia and symptoms like polyuria and polydipsia.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Autoimmune +ve Normoglycemic presymptomatic:&nbsp;</strong>Represents stage 1 or 2 where glucose levels are still normal.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Autoimmune -ve Normoglycemic presymptomatic:&nbsp;</strong>Incorrect as autoimmunity is present in Type 1 DM.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Autoimmune -ve dysglycemic presymptomatic:&nbsp;</strong>Not typical of Type 1 DM where autoimmunity drives dysglycemia.&nbsp;</span></p>",
    "correct_choice_id": 267742,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85733,
    "choices": [
      {
        "id": 341468,
        "text": "<p><span style=\"font-size:14.0pt;\">ACTH</span></p>"
      },
      {
        "id": 341469,
        "text": "<p><span style=\"font-size:14.0pt;\">Growth hormone</span></p>"
      },
      {
        "id": 341470,
        "text": "<p><span style=\"font-size:14.0pt;\">Prolactin</span></p>"
      },
      {
        "id": 341471,
        "text": "<p><span style=\"font-size:14.0pt;\">Thyrotropin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old man presents with headaches, fatigue, visual disturbances. He has sarcoidosis, mild hypercalcemia, and MRI shows mass in hypothalamus and pituitary stalk. Which of the following pituitary hormones is most likely elevated in this patient?</span></p>",
    "unique_key": "Q8314969",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416486,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Prolactin&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mass lesions in the hypothalamus or pituitary stalk can disrupt dopamine inhibition, causing elevated prolactin (hyperprolactinemia) which explains the symptoms.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ACTH:&nbsp;</strong>Not typically elevated unless there is an ACTH-secreting tumor.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Growth hormone:&nbsp;</strong>Growth hormone elevation unrelated to this presentation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Thyrotropin: </strong>Elevated TSH would cause hyperthyroidism, not typically linked here.&nbsp;</span></p>",
    "correct_choice_id": 341470,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85734,
    "choices": [
      {
        "id": 341472,
        "text": "<p><span style=\"font-size:14.0pt;\">B- Normal</span></p>"
      },
      {
        "id": 341473,
        "text": "<p><span style=\"font-size:14.0pt;\">C- Primary polydipsia</span></p>"
      },
      {
        "id": 341474,
        "text": "<p><span style=\"font-size:14.0pt;\">D- Nephrogenic DI</span></p>"
      },
      {
        "id": 341475,
        "text": "<p><span style=\"font-size:14.0pt;\">B- Central DI</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Identify the correct pair?</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_M4tMvQ8.png\" width=\"459\" height=\"364\"></span></p>",
    "unique_key": "Q7281155",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416767,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) D-Nephrogenic DI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">On the graph, curve D shows consistently low urine osmolality that does not rise with either water deprivation or desmopressin administration. This pattern is characteristic of&nbsp;nephrogenic diabetes insipidus (DI), where the kidneys are unable to respond to antidiuretic hormone (ADH) even after desmopressin, resulting in persistently dilute urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. B \u2013 Normal:&nbsp;</strong>Incorrect; B responds to water deprivation and desmopressin but is not normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. C - Primary polydipsia:&nbsp;</strong>C shows improvement with desmopressin, more typical for central DI, not primary polydipsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. B - Central DI:&nbsp;</strong>In central DI, urine osmolality sharply rises only after desmopressin, which matches pattern C, not B.</span></p>",
    "correct_choice_id": 341474,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85777,
    "choices": [
      {
        "id": 341640,
        "text": "<p><span style=\"font-size:14.0pt;\">Sodium retention</span></p>"
      },
      {
        "id": 341641,
        "text": "<p><span style=\"font-size:14.0pt;\">Lipolysis</span></p>"
      },
      {
        "id": 341642,
        "text": "<p><span style=\"font-size:14.0pt;\">Reduced insulin sensitivity</span></p>"
      },
      {
        "id": 341643,
        "text": "<p><span style=\"font-size:14.0pt;\">Antilipolysis&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which function of growth hormone (GH) is specifically mediated via IGF-1?</span></p>",
    "unique_key": "Q5900708",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416768,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Antilipolysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The antilipolytic effect of growth hormone is indirectly mediated by IGF-1, which promotes fat storage by opposing GH\u2019s direct lipolytic actions.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Sodium retention:</strong> Directly mediated by GH, not IGF-1.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Lipolysis:&nbsp;</strong>A direct effect of GH, independent of IGF-1.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Reduced insulin sensitivity:&nbsp;</strong>Also a direct effect of GH on peripheral tissues, not IGF-1.&nbsp;</span></p>",
    "correct_choice_id": 341643,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92198,
    "choices": [
      {
        "id": 367108,
        "text": "<p><span style=\"font-size:14.0pt;\">Dexamethasone&nbsp;</span></p>"
      },
      {
        "id": 367109,
        "text": "<p><span style=\"font-size:14.0pt;\">Fludrocortisone&nbsp;</span></p>"
      },
      {
        "id": 367110,
        "text": "<p><span style=\"font-size:14.0pt;\">Norepinephrine&nbsp;</span></p>"
      },
      {
        "id": 367111,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydrocortisone&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 33-year-old man collapses during a family vacation. At the hospital, blood pressure is 86/52 mmHg and random blood sugar is 49 mg/dl. His wife says he has been on treatment for Addison's disease for two years but had forgotten his medication for the trip. What is the drug of choice for this patient?&nbsp;&nbsp;</span></p>",
    "unique_key": "Q1491251",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416769,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hydrocortisone&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hydrocortisone replaces both glucocorticoid and some mineralocorticoid activity and is the drug of choice for acute adrenal crisis in Addison\u2019s disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Dexamethasone:&nbsp;</strong>Has no mineralocorticoid activity and is less preferred in crisis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Fludrocortisone:&nbsp;</strong>Only mineralocorticoid, not sufficient alone for adrenal crisis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Norepinephrine:&nbsp;</strong>A vasopressor; supportive but not a hormone replacement.&nbsp;</span></p>",
    "correct_choice_id": 367111,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92199,
    "choices": [
      {
        "id": 367112,
        "text": "<p><span style=\"font-size:14.0pt;\">Early intensive glycemic control has long-term benefits on microvascular and macrovascular complications, even if strict control is not maintained later.&nbsp;</span></p>"
      },
      {
        "id": 367113,
        "text": "<p><span style=\"font-size:14.0pt;\">Good glycemic control only in longstanding disease prevents complications.&nbsp;</span></p>"
      },
      {
        "id": 367114,
        "text": "<p><span style=\"font-size:14.0pt;\">Early detection and management of dyslipidemia completely prevents metabolic memory.&nbsp;</span></p>"
      },
      {
        "id": 367115,
        "text": "<p><span style=\"font-size:14.0pt;\">High HbA1c in longstanding disease has no effect on future complications.&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 53-year-old woman is brought to the emergency department after she collapsed suddenly while standing. She also reports left-sided chest pain. Legacy effect (metabolic memory) in diabetes mellitus refers to which of the following observations?&nbsp;</span></p>",
    "unique_key": "Q8994956",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416770,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Early intensive glycemic control has long-term benefits on&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">microvascular and macrovascular complications, even if strict control is not maintained later.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Good glycemic control only in longstanding disease prevents complications.&nbsp;</strong>Incorrect; early glycemic control is key.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Early detection and management of dyslipidemia completely prevents metabolic memory.&nbsp;</strong>Incorrect; metabolic memory involves more factors than dyslipidemia management.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;High HbA1c in longstanding disease has no effect on future complications.&nbsp;</strong>Incorrect; it significantly increases risk.&nbsp;</span></p>",
    "correct_choice_id": 367112,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74367,
    "choices": [
      {
        "id": 296389,
        "text": "<p><span style=\"font-size:14.0pt;\">2 is increased</span></p>"
      },
      {
        "id": 296390,
        "text": "<p><span style=\"font-size:14.0pt;\">1+2+3 is decreased</span></p>"
      },
      {
        "id": 296391,
        "text": "<p><span style=\"font-size:14.0pt;\">5 is increased</span></p>"
      },
      {
        "id": 296392,
        "text": "<p><span style=\"font-size:14.0pt;\">1+3+4 is decreased</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The image below demonstrates normal lung volumes and capacities. Which of the following changes is unlikely in a \u201cpink puffer\u201d?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-15%20125716.jpg\" width=\"622\" height=\"364\"></span></p>",
    "unique_key": "Q2231958",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416771,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span><strong>&nbsp;</strong><span style=\"font-size:14.0pt;\"><strong>B) 1+2+3 is decreased</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a \u201cpink puffer\u201d (emphysema dominant COPD),&nbsp;total lung capacity (1+2+3)&nbsp;is&nbsp;not decreased; rather, it is typically increased due to air trapping and hyperinflation. Options A, C, and D describe findings consistent with emphysema (increased residual volume, increased FRC, and decreased vital capacity with inspiratory reserve volume).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 2 is increased:&nbsp;</strong>Functional residual capacity (FRC) is increased in pink puffers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 5 is increased:&nbsp;</strong>Residual volume (RV) is increased due to air trapping.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 1+3+4 is decreased:&nbsp;</strong>Inspiratory and expiratory reserve volumes and vital capacity (inspiratory reserve + tidal + expiratory reserve) are decreased due to hyperinflation.</span></p>",
    "correct_choice_id": 296390,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74385,
    "choices": [
      {
        "id": 296461,
        "text": "<p><span style=\"font-size:14.0pt;\">MRI</span></p>"
      },
      {
        "id": 296462,
        "text": "<p><span style=\"font-size:14.0pt;\">Fiberoptic bronchoscopy</span></p>"
      },
      {
        "id": 296463,
        "text": "<p><span style=\"font-size:14.0pt;\">HRCT thorax</span></p>"
      },
      {
        "id": 296464,
        "text": "<p><span style=\"font-size:14.0pt;\">Rigid bronchoscopy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old chronic smoker presented with mild recurrent hemoptysis without fever or weight loss. The chest X-ray appears normal and the sputum is negative for AFB. Which of the following is the next best step?</span></p>",
    "unique_key": "Q6642815",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416812,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span><strong>&nbsp;</strong><span style=\"font-size:14.0pt;\"><strong>C) HRCT thorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HRCT thorax provides detailed imaging to detect subtle lung pathology such as small tumors or bronchiectasis not visible on plain X-rays, making it the best next step for evaluating hemoptysis with normal X-ray.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;MRI:</strong> Less sensitive and not the first-line investigation for lung parenchyma evaluation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Fiberoptic bronchoscopy:&nbsp;</strong>Useful after imaging to localize bleeding source but not first step with normal X-ray.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Rigid bronchoscopy:&nbsp;</strong>More invasive and used mainly for therapeutic interventions or severe bleeding.&nbsp;</span></p>",
    "correct_choice_id": 296463,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74411,
    "choices": [
      {
        "id": 296565,
        "text": "<p><span style=\"font-size:14.0pt;\">Right to left shunt</span></p>"
      },
      {
        "id": 296566,
        "text": "<p><span style=\"font-size:14.0pt;\">Ventilation/Perfusion mismatch</span></p>"
      },
      {
        "id": 296567,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypoventilation</span></p>"
      },
      {
        "id": 296568,
        "text": "<p><span style=\"font-size:14.0pt;\">Alveolar membrane damage</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45 year old patient came with hypoxemia and a normal alveolar-arterial oxygen gradient. What can be the cause?</span></p>",
    "unique_key": "Q1521342",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416813,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hypoventilation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hypoventilation causes hypoxemia with a normal or low A-a gradient because both alveolar and arterial oxygen levels decrease proportionally without mismatch or shunting.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Right to left shunt:</strong> Leads to increased A-a gradient due to blood bypassing ventilated alveoli.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Ventilation/Perfusion mismatch:&nbsp;</strong>Increases A-a gradient because of uneven ventilation-perfusion.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Alveolar membrane damage:&nbsp;</strong>Causes diffusion impairment and increased A-a gradient.&nbsp;</span></p>",
    "correct_choice_id": 296567,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74418,
    "choices": [
      {
        "id": 296593,
        "text": "<p><span style=\"font-size:14.0pt;\">Iloprost</span></p>"
      },
      {
        "id": 296594,
        "text": "<p><span style=\"font-size:14.0pt;\">Ambrisentan</span></p>"
      },
      {
        "id": 296595,
        "text": "<p><span style=\"font-size:14.0pt;\">Nifedipine</span></p>"
      },
      {
        "id": 296596,
        "text": "<p><span style=\"font-size:14.0pt;\">Epoprostenol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old female patient with class II pulmonary hypertension presents with a positive vasoreactivity test. Which of the following is used in the next step of management?&nbsp;</span></p>",
    "unique_key": "Q6420700",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416814,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span><strong>&nbsp;</strong><span style=\"font-size:14.0pt;\"><strong>C) Nifedipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nifedipine, a calcium channel blocker, is the first-line treatment for patients with pulmonary hypertension who have a positive vasoreactivity response.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Iloprost:</strong> Used as a prostacyclin analog for severe cases, not initial therapy after a positive vasoreactivity test.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Ambrisentan:&nbsp;</strong>An endothelin receptor antagonist used for pulmonary hypertension but not first for vasoreactive patients.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Epoprostenol:&nbsp;</strong>Reserved for advanced pulmonary hypertension refractory to other treatments.&nbsp;</span></p>",
    "correct_choice_id": 296595,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74463,
    "choices": [
      {
        "id": 296773,
        "text": "<p><span style=\"font-size:14.0pt;\">Mechanical ventilation&nbsp;</span></p>"
      },
      {
        "id": 296774,
        "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone plus azithromycin</span></p>"
      },
      {
        "id": 296775,
        "text": "<p><span style=\"font-size:14.0pt;\">Amoxicillin plus clavulanic acid</span></p>"
      },
      {
        "id": 296776,
        "text": "<p><span style=\"font-size:14.0pt;\">LMW heparin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient in emergency admitted to ICU based on the appropriate score with the following CXR presentation. What is the treatment of choice in this patient?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-15%20141146.jpg\" width=\"465\" height=\"362\"></span></p>",
    "unique_key": "Q7143691",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416815,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ceftriaxone plus azithromycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The chest X-ray demonstrates&nbsp;consolidation of the right lower lobe, a classic finding for&nbsp;community-acquired pneumonia&nbsp;in a hospitalized patient. The recommended treatment of choice for severe community-acquired pneumonia requiring ICU admission is the combination of a third-generation cephalosporin (e.g., ceftriaxone) plus a macrolide (e.g., azithromycin), which provides broad coverage including Streptococcus pneumoniae and atypical organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mechanical ventilation:&nbsp;</strong>Indicated only if respiratory failure is present, not routinely for pneumonia with adequate gas exchange.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Amoxicillin plus clavulanic acid:&nbsp;</strong>Not adequate for severe, hospitalized patients or ICU admission.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. LMW heparin:&nbsp;</strong>Used for prevention/treatment of thromboembolism, not for pneumonia.</span></p>",
    "correct_choice_id": 296774,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74471,
    "choices": [
      {
        "id": 296805,
        "text": "<p><span style=\"font-size:14.0pt;\">Chest wall neuromuscular disease</span></p>"
      },
      {
        "id": 296806,
        "text": "<p><span style=\"font-size:14.0pt;\">Sarcoidosis</span></p>"
      },
      {
        "id": 296807,
        "text": "<p><span style=\"font-size:14.0pt;\">Idiopathic pulmonary fibrosis</span></p>"
      },
      {
        "id": 296808,
        "text": "<p><span style=\"font-size:14.0pt;\">Bronchiectasis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The given image shows a normal graph on the left and the patient's graph on the right. Which of the following diagnoses can be inferred from the graph?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-15%20150244.jpg\" width=\"577\" height=\"365\"></span></p>",
    "unique_key": "Q2974469",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416816,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;Bronchiectasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image compares normal and patient spirometry curves, showing a greater reduction in&nbsp;FEV1&nbsp;than&nbsp;FVC&nbsp;in the patient, resulting in a decreased FEV1/FVC ratio. This pattern is characteristic of&nbsp;obstructive lung disease, such as bronchiectasis, where airway damage impairs rapid expiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Chest wall neuromuscular disease:&nbsp;</strong>Usually causes a restrictive pattern with proportionately reduced FVC and FEV1, not an isolated drop in FEV1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Sarcoidosis:</strong>Typically produces a restrictive pattern, not obstructive spirometry changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Idiopathic pulmonary fibrosis:&nbsp;</strong>Also presents as restrictive disease with reduced lung volumes but a relatively preserved FEV1/FVC ratio.</span></p>",
    "correct_choice_id": 296808,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74479,
    "choices": [
      {
        "id": 296837,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased tone of the pharyngeal muscles worsens obstruction</span></p>"
      },
      {
        "id": 296838,
        "text": "<p><span style=\"font-size:14.0pt;\">Fall of oxygen saturation triggers waking episodes at night</span></p>"
      },
      {
        "id": 296839,
        "text": "<p><span style=\"font-size:14.0pt;\">Episodes of apnea increase work of breathing</span></p>"
      },
      {
        "id": 296840,
        "text": "<p><span style=\"font-size:14.0pt;\">PaO2 is normal during the day</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male presented to OPD with complaints of excessive daytime sleepiness, and his wife also complains that he snores a lot at night during sleep. Which of the following is incorrect regarding his condition?</span></p>",
    "unique_key": "Q4510788",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416897,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Increased tone of the pharyngeal muscles worsens obstruction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In obstructive sleep apnea, decreased tone (not increased) of pharyngeal muscles worsens airway obstruction during sleep.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Fall of oxygen saturation triggers waking episodes at night:&nbsp;</strong>Correct; hypoxia causes arousals to restore airflow.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Episodes of apnea increase work of breathing:&nbsp;</strong>True; repeated apneas increase respiratory effort.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;PaO2 is normal during the day:&nbsp;</strong>Daytime oxygen levels often normalize despite nocturnal hypoxemia.&nbsp;</span></p>",
    "correct_choice_id": 296837,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74483,
    "choices": [
      {
        "id": 296853,
        "text": "<p><span style=\"font-size:14.0pt;\">Syrup Dextromethorphan with bromhexine</span></p>"
      },
      {
        "id": 296854,
        "text": "<p><span style=\"font-size:14.0pt;\">Syrup Codeine</span></p>"
      },
      {
        "id": 296855,
        "text": "<p><span style=\"font-size:14.0pt;\">Syrup Dextromethorphan</span></p>"
      },
      {
        "id": 296856,
        "text": "<p><span style=\"font-size:14.0pt;\">Syrup Bromhexine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old patient presents with fever, cough, and tenacious white sputum. Which of the following should be used for treatment?</span></p>",
    "unique_key": "Q7622346",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416898,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Syrup Bromhexine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bromhexine is a mucolytic agent that helps liquefy thick sputum by breaking down mucus, improving clearance.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Syrup Dextromethorphan with bromhexine:&nbsp;</strong>Combining an antitussive with a mucolytic is less appropriate for productive cough.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Syrup Codeine:&nbsp;</strong>An antitussive not recommended with productive cough due to sputum retention risk.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Syrup Dextromethorphan:</strong> Suppresses cough reflex; not ideal when sputum clearance is needed.&nbsp;</span></p>",
    "correct_choice_id": 296856,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35569,
    "choices": [
      {
        "id": 142083,
        "text": "<p><span style=\"font-size:18px;\">Bronchial asthma</span></p>"
      },
      {
        "id": 142084,
        "text": "<p><span style=\"font-size:18px;\">Chronic bronchitis</span></p>"
      },
      {
        "id": 142085,
        "text": "<p><span style=\"font-size:18px;\">Hypersensitivity pneumonitis</span></p>"
      },
      {
        "id": 142086,
        "text": "<p><span style=\"font-size:18px;\">Idiopathic pulmonary fibrosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 35-year-old man comes to the clinic for evaluation of exertional dyspnea and dry cough for 8 months. Oxygen saturation on room air while lying down is 96% and drops to 88% after 6 minutes of walking. Examination shows fine crackles in both lower lungs. Chest x-ray reveals reticular densities in both lung fields. Lung biopsy shows an infiltration of inflammatory cells, predominantly lymphocytes, as well as poorly formed noncaseating granulomas and moderate alveolar septal fibrosis. Which of the following is the most likely diagnosis?</span></p>",
    "unique_key": "Q2055227",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416899,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Hypersensitivity pneumonitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of lymphocytic infiltration, noncaseating granulomas, and fibrosis with exertional desaturation suggests hypersensitivity pneumonitis due to repeated antigen exposure.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Bronchial asthma:</strong> Characterized by reversible airway obstruction, not fibrosis or granulomas.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Chronic bronchitis:</strong> A clinical diagnosis with mucus hypersecretion, not granulomatous inflammation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Idiopathic pulmonary fibrosis:</strong> Usually shows usual interstitial pneumonia pattern without granulomas.&nbsp;</span></p>",
    "correct_choice_id": 142085,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74437,
    "choices": [
      {
        "id": 296669,
        "text": "<p><span style=\"font-size:14.0pt;\">Vascular hydrostatic pressure increased, Oncotic pressure increased, lymphatic flow normal&nbsp;</span></p>"
      },
      {
        "id": 296670,
        "text": "<p><span style=\"font-size:14.0pt;\">Vascular hydrostatic pressure normal, Oncotic pressure normal, lymphatic flow decreased</span></p>"
      },
      {
        "id": 296671,
        "text": "<p><span style=\"font-size:14.0pt;\">Vascular hydrostatic pressure increased, Oncotic pressure normal, lymphatic flow increased</span></p>"
      },
      {
        "id": 296672,
        "text": "<p><span style=\"font-size:14.0pt;\">Vascular hydrostatic pressure normal, Oncotic pressure decreased, lymphatic flow increased</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man comes to the OPD due to worsening dyspnea on exertion for the past 3 months. The patient has had a nonproductive cough but no chest pain, fever, or chills. He was diagnosed with hypertension several years ago but takes no medications. Physical examination shows bilateral inspiratory crackles as well as dullness to percussion and decreased breath sounds at the right lung base. Chest x-ray reveals a right-sided pleural effusion. Which of the following pleuropulmonary changes are most likely present in this patient?</span></p>",
    "unique_key": "Q6114935",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416900,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vascular hydrostatic pressure increased, Oncotic pressure normal, lymphatic flow increased</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Increased hydrostatic pressure from conditions like heart failure causes pleural effusion with normal oncotic pressure and compensatory increased lymphatic flow.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Vascular hydrostatic pressure increased, Oncotic pressure increased, lymphatic flow normal:&nbsp;</strong>Uncommon combination; oncotic pressure typically decreases in fluid accumulation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Vascular hydrostatic pressure normal, Oncotic pressure normal, lymphatic flow decreased:&nbsp;</strong>Decreased lymphatic flow typically causes chylous or malignant effusions, not this scenario.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Vascular hydrostatic pressure normal, Oncotic pressure decreased, lymphatic flow increased:&nbsp;</strong>Seen in hypoalbuminemia, but normally oncotic pressure is maintained in hypertension-related effusions.&nbsp;</span></p>",
    "correct_choice_id": 296671,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74442,
    "choices": [
      {
        "id": 296689,
        "text": "<p><span style=\"font-size:14.0pt;\">Periodic Acid Schiff - Positive, Diastase - Sensitive&nbsp;</span></p>"
      },
      {
        "id": 296690,
        "text": "<p><span style=\"font-size:14.0pt;\">Periodic Acid Schiff - Positive, Diastase -Resistant</span></p>"
      },
      {
        "id": 296691,
        "text": "<p><span style=\"font-size:14.0pt;\">Periodic Acid Schiff - Negative, Diastase -Sensitive&nbsp;</span></p>"
      },
      {
        "id": 296692,
        "text": "<p><span style=\"font-size:14.0pt;\">Periodic Acid Schiff - Negative, Diastase&nbsp; Resistant</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents with progressive shortness of breath over the past few years. He has no history of smoking and works as an accountant. Physical examination reveals diminished breath sounds and hyperresonance to percussion. A chest X-ray shows basilar emphysema. His liver function tests are mildly elevated.&nbsp;Which of the following properties correlate with the histopathology staining in this condition?</span></p>",
    "unique_key": "Q6006779",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416901,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Periodic Acid Schiff - Positive, Diastase - Resistant&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Alpha-1 antitrypsin deficiency-associated emphysema shows PAS-positive, diastase-resistant globules in hepatocytes.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Periodic Acid Schiff - Positive, Diastase \u2013 Sensitive:&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">Typical of glycogen deposits, not alpha-1 antitrypsin globules.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Periodic Acid Schiff - Negative, Diastase \u2013 Sensitive:&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">Incorrect; these globules are PAS positive.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Periodic Acid Schiff - Negative, Diastase&nbsp; Resistant:&nbsp;D</strong>oes not describe the histology of alpha-1 antitrypsin deficiency.&nbsp;</span></p>",
    "correct_choice_id": 296690,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74493,
    "choices": [
      {
        "id": 296893,
        "text": "<p><span style=\"font-size:14.0pt;\">1-2-3-4&nbsp;</span></p>"
      },
      {
        "id": 296894,
        "text": "<p><span style=\"font-size:14.0pt;\">1-4-2-3</span></p>"
      },
      {
        "id": 296895,
        "text": "<p><span style=\"font-size:14.0pt;\">4-3-1-2</span></p>"
      },
      {
        "id": 296896,
        "text": "<p><span style=\"font-size:14.0pt;\">4-2-3-1&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Arrange the following in ascending order of their normal values</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Vital capacity</span></p><p><span style=\"font-size:14.0pt;\">2. FRC&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">3. Inspiratory capacity</span></p><p><span style=\"font-size:14.0pt;\">4. Tidal Volume</span></p>",
    "unique_key": "Q4763993",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416902,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 4-2-3-1&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Normal lung volumes from smallest to largest are tidal volume (4), functional residual capacity (2), inspiratory capacity (3), and vital capacity (1).&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A, B, C:</strong> Incorrect sequences that do not reflect normal lung volume values.&nbsp;</span></p>",
    "correct_choice_id": 296896,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74518,
    "choices": [
      {
        "id": 296993,
        "text": "<p><span style=\"font-size:14.0pt;\">Add Fluticasone MDI two times a day</span></p>"
      },
      {
        "id": 296994,
        "text": "<p><span style=\"font-size:14.0pt;\">Shift to MDI Salmeterol two times a day</span></p>"
      },
      {
        "id": 296995,
        "text": "<p><span style=\"font-size:14.0pt;\">Add Prednisolone 10mg</span></p>"
      },
      {
        "id": 296996,
        "text": "<p><span style=\"font-size:14.0pt;\">Continue the current management</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old male who is a known case of bronchial asthma presented for a routine follow-up. PFT was done earlier\u2014his FEV1 was 70%, which improved to 83% after bronchodilator nebulization. He was already on MDI Albuterol daily. On questioning, it seems like he is being symptomatic for at least 2 times per week and is waking up in the nights due to symptoms at least once per week. On examination, there are scattered rhonchi. What should be done?&nbsp;</span></p>",
    "unique_key": "Q6788621",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416903,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Add Fluticasone MDI two times a day</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Adding inhaled corticosteroids like fluticasone is indicated for symptomatic asthma despite bronchodilator use, to control airway inflammation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Shift to MDI Salmeterol two times a day:&nbsp;</strong>Long-acting beta-agonists should be combined with inhaled corticosteroids, not used alone.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Add Prednisolone 10mg:&nbsp;</strong>Systemic steroids are for exacerbations or severe asthma, not routine step-up.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Continue the current management:&nbsp;</strong>Current symptoms indicate treatment intensification is needed.&nbsp;</span></p>",
    "correct_choice_id": 296993,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74521,
    "choices": [
      {
        "id": 297005,
        "text": "<p><span style=\"font-size:14.0pt;\">Bronchial breath sounds</span></p>"
      },
      {
        "id": 297006,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased tactile fremitus&nbsp;</span></p>"
      },
      {
        "id": 297007,
        "text": "<p><span style=\"font-size:14.0pt;\">Fine inspiratory crackles</span></p>"
      },
      {
        "id": 297008,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased resonance on percussion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 66-year-old man comes to the office due to increasing shortness of breath over the past 3 weeks. He has had a nonproductive cough for several months, which he attributes to allergies, but also notes a 9-kg unintentional weight loss over this time. He has a 50-pack-year smoking history. Chest x-ray is shown below. Which of the following would be the expected physical examination finding over the right lower chest?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7wp3SvD.png\" width=\"498\" height=\"375\"></p>",
    "unique_key": "Q6372840",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416904,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Decreased tactile fremitus&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The chest X-ray shows extensive right-sided pleural effusion with complete opacification of the lower lung field and blunting of the costophrenic angle. On physical examination, pleural effusion typically produces decreased tactile fremitus over the affected area due to fluid preventing sound transmission through the lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bronchial breath sounds:&nbsp;</strong>May be heard over consolidation, not effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fine inspiratory crackles:&nbsp;</strong>Associated with interstitial fibrosis or alveolar fluid, not pleural fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased resonance on percussion:&nbsp;</strong>Seen in pneumothorax, not pleural effusion; effusion produces dullness on percussion.</span></p>",
    "correct_choice_id": 297006,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 61878,
    "choices": [
      {
        "id": 246781,
        "text": "<p><span style=\"font-size:14.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 246782,
        "text": "<p><span style=\"font-size:14.0pt;\">Small cell carcinoma</span></p>"
      },
      {
        "id": 246783,
        "text": "<p><span style=\"font-size:14.0pt;\">Adenocarcinoma</span></p>"
      },
      {
        "id": 246784,
        "text": "<p><span style=\"font-size:14.0pt;\">Large cell carcinoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old chronic smoker presents with weight loss, hemoptysis and TTF-1 positivity. What is the possible diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-130958.png\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
    "unique_key": "Q7450959",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416905,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)</strong></span><span style=\"font-size:12pt;\"> </span><span style=\"font-size:14.0pt;\"><strong>Adenocarcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">TTF-1 (thyroid transcription factor-1) positivity is a marker commonly associated with&nbsp;lung adenocarcinoma&nbsp;and small cell carcinoma but is most classically used to identify adenocarcinoma in lung cancers. Adenocarcinoma is the most common type of lung cancer in smokers and non-smokers alike and often presents with weight loss and hemoptysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Squamous cell carcinoma:&nbsp;</strong>Usually TTF-1 negative; more commonly shows keratinization and intercellular bridges.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Small cell carcinoma:&nbsp;</strong>May be TTF-1 positive but typically presents with rapid progression and different histopathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Large cell carcinoma:&nbsp;</strong>Typically lacks TTF-1 expression and has a less differentiated histology.</span></p>",
    "correct_choice_id": 246783,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73890,
    "choices": [
      {
        "id": 294497,
        "text": "<p><span style=\"font-size:14.0pt;\">Air-borne&nbsp;</span></p>"
      },
      {
        "id": 294498,
        "text": "<p><span style=\"font-size:14.0pt;\">Feco-oral&nbsp;</span></p>"
      },
      {
        "id": 294499,
        "text": "<p><span style=\"font-size:14.0pt;\">Droplet</span></p>"
      },
      {
        "id": 294500,
        "text": "<p><span style=\"font-size:14.0pt;\">Hematogeneous</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the route of dissemination of the following disease?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jfaZ8Fm.png\" width=\"265\" height=\"304\"></span></p>",
    "unique_key": "Q1716738",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416906,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hematogeneous</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The lung specimen shows multiple&nbsp;millet-sized nodules throughout the parenchyma, classic for&nbsp;miliary tuberculosis. This pattern results from&nbsp;hematogenous dissemination&nbsp;of Mycobacterium tuberculosis, spreading the infection widely via the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Air-borne:&nbsp;</strong>Airborne transmission is the mode of initial infection, not the cause of disseminated miliary disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Feco-oral:&nbsp;</strong>Not applicable for tuberculosis or miliary spread.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Droplet:&nbsp;</strong>Droplet transmission applies to some respiratory infections but not the disseminated spread of tuberculosis.</span></p>",
    "correct_choice_id": 294500,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 68602,
    "choices": [
      {
        "id": 273497,
        "text": "<p><span style=\"font-size:18px;\">Pulmonary hypertension</span></p>"
      },
      {
        "id": 273498,
        "text": "<p><span style=\"font-size:18px;\">Asthma&nbsp;</span></p>"
      },
      {
        "id": 273499,
        "text": "<p><span style=\"font-size:18px;\">Wegener\u2019s granulomatosis</span></p>"
      },
      {
        "id": 273500,
        "text": "<p><span style=\"font-size:18px;\">Microscopic polyangiitis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">A 36-year-old woman is referred for evaluation because of hematuria and haemoptysis since 2 weeks. DLCO is 120% of normal with normal lung volumes. What is the likely diagnosis in this patient?</span></p>",
    "unique_key": "Q1871166",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416907,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Microscopic polyangiitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Microscopic polyangiitis is a small-vessel vasculitis causing rapidly progressive glomerulonephritis and pulmonary capillaritis, presenting with hematuria and hemoptysis. Elevated DLCO suggests alveolar hemorrhage due to increased carbon monoxide uptake.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Pulmonary hypertension:&nbsp;</strong>Does not cause hematuria and usually lowers DLCO.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Asthma:&nbsp;</strong>Causes airway obstruction, not hematuria or hemoptysis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Wegener\u2019s granulomatosis:&nbsp;</strong>Also causes hematuria and hemoptysis but typically associated with granulomas and elevated c-ANCA, which differentiates it from microscopic polyangiitis.&nbsp;</span></p>",
    "correct_choice_id": 273500,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25688,
    "choices": [
      {
        "id": 102702,
        "text": "<p><span style=\"font-size:14.0pt;\">Dead space ventilation</span></p>"
      },
      {
        "id": 102703,
        "text": "<p><span style=\"font-size:14.0pt;\">Effort dependent hypoventilation</span></p>"
      },
      {
        "id": 102704,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypoxic vasoconstriction&nbsp;</span></p>"
      },
      {
        "id": 102705,
        "text": "<p><span style=\"font-size:14.0pt;\">Intrapulmonary shunting&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">64-year-old man comes to the emergency department due to 2 days of fever, chills, productive cough. The patient has a history of hypertension, hyperlipidemia, and type 2 diabetes mellitus. Oxygen saturation is 94% on room air when lying on his right side but drops to 89% when he lies on his left. Dullness to percussion and bronchial breath sounds are present on the left side. Imaging is shown here. Which of the following pathophysiologic mechanisms in the left lung is most responsible for the drop in oxygen saturation after the change in position?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/29/picture11.jpg\" alt=\"\" width=\"300\" height=\"317\"></span></p>",
    "unique_key": "Q4852279",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416908,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Intrapulmonary shunting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient's chest X-ray reveals left-sided consolidation, and clinical examination confirms findings of pneumonia with dullness to percussion and bronchial breath sounds on the left. When the patient lies on his left side (affected side down), more blood flows to poorly ventilated/consolidated regions, resulting in&nbsp;intrapulmonary shunting\u2014blood passes through non-aerated parts of the lung without gas exchange, causing a drop in oxygen saturation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dead space ventilation:&nbsp;</strong>Refers to ventilation of non-perfused alveoli, which is not the primary issue in consolidation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Effort dependent hypoventilation:&nbsp;</strong>No evidence is provided for effort-dependent issues; hypoxemia is positional and related to lung pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hypoxic vasoconstriction:&nbsp;</strong>May occur, but the shunt effect dominates in severe consolidation</span></p>",
    "correct_choice_id": 102705,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 70008,
    "choices": [
      {
        "id": 279105,
        "text": "<p><span style=\"font-size:14.0pt;\">FEV1 low, FVC low, RV normal, TLC low&nbsp;</span></p>"
      },
      {
        "id": 279106,
        "text": "<p><span style=\"font-size:14.0pt;\">FEV1 low, FVC low, RV high, TLC high</span></p>"
      },
      {
        "id": 279107,
        "text": "<p><span style=\"font-size:14.0pt;\">FEV1 high, FVC low, RV normal, TLC low</span></p>"
      },
      {
        "id": 279108,
        "text": "<p><span style=\"font-size:14.0pt;\">FEV1 low, FVC low, RV high, TLC low</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man comes to the OPD with reports of dyspnea on exertion and decreased exercise tolerance. His medical history is unremarkable, and he has no history of childhood asthma or cough. The patient has gained almost 30kg over the past 4 years due to a sedentary lifestyle. He currently has a BMI of 41 kg/m<sup>2</sup>. His respiratory rate is 22/min and pulse oximetry is 93% on room air at rest. Physical examination is notable for central obesity. Lungs are clear on auscultation bilaterally. Which of the following changes are most likely to be seen on pulmonary function testing in this patient?</span></p>",
    "unique_key": "Q9656627",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416909,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) FEV1 low, FVC low, RV normal, TLC low&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Obesity causes a restrictive pattern in PFTs with decreased FEV1, FVC, and total lung capacity (TLC), while residual volume (RV) typically remains normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. FEV1 low, FVC low, RV high, TLC high:&nbsp;</strong>Typical of obstructive lung disease, not obesity-related restriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. FEV1 high, FVC low, RV normal, TLC low:&nbsp;</strong>An uncommon pattern; FEV1 usually decreases alongside FVC in restriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. FEV1 low, FVC low, RV high, TLC low:&nbsp;</strong>Increased RV is unusual in pure restrictive conditions like obesity.</span></p>",
    "correct_choice_id": 279105,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 37113,
    "choices": [
      {
        "id": 148231,
        "text": "<p><span style=\"font-size:14.0pt;\">PDE 4 inhibition: Bronchodilation</span></p>"
      },
      {
        "id": 148232,
        "text": "<p><span style=\"font-size:14.0pt;\">Deactivation of histone deacetylase: Anti-inflammatory</span></p>"
      },
      {
        "id": 148233,
        "text": "<p><span style=\"font-size:14.0pt;\">PDE 3 inhibition: Cardiac effects</span></p>"
      },
      {
        "id": 148234,
        "text": "<p><span style=\"font-size:14.0pt;\">Adenosine antagonism: Diuresis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">All of the following are true about theophylline except:</span></p>",
    "unique_key": "Q5263313",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416910,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Deactivation of histone deacetylase: Anti-inflammatory</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Theophylline actually activates histone deacetylase, which contributes to its anti-inflammatory effects; deactivation would be incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. PDE 4 inhibition: Bronchodilation:&nbsp;</strong>Correct, PDE4 inhibition leads to bronchodilation in airway smooth muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. PDE 3 inhibition: Cardiac effects:&nbsp;</strong>True, PDE3 inhibition affects cardiac contractility and heart rate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adenosine antagonism: Diuresis:&nbsp;</strong>Correct; blocking adenosine receptors promotes diuresis.</span></p>",
    "correct_choice_id": 148232,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 40307,
    "choices": [
      {
        "id": 160948,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Aspirated foreign body</span></p>"
      },
      {
        "id": 160949,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">U/L vocal cord paralysis</span></p>"
      },
      {
        "id": 160950,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Subglottic stenosis</span></p>"
      },
      {
        "id": 160951,
        "text": "<p><span style=\"font-size:14.0pt;\">COPD</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">65-year-old man presents with progressive dyspnoea &amp; pulmonary function testing was done. FEV1 is 2.5 L (78% predicted), FVC is 4.00 L (94% predicted), and the FEV1/FVC ratio is 62.5%. The flow-volume curve is shown. What is the most likely cause?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-171028.png\" alt=\"\" width=\"300\" height=\"265\"></span></p>",
    "unique_key": "Q3657310",
    "question_audio": null,
    "question_video": null,
    "map_id": 33416911,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Subglottic stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The flow-volume curve shows&nbsp;flattening of both the expiratory and inspiratory limbs, which is characteristic of a&nbsp;fixed upper airway obstruction&nbsp;like subglottic stenosis. This pattern differs from the scooped-out expiratory limb seen in obstructive lung diseases and variable flattening seen in vocal cord paralysis or aspiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Aspirated foreign body:&nbsp;</strong>Typically causes a focal obstruction, not the fixed pattern seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. U/L vocal cord paralysis:&nbsp;</strong>Produces variable extrathoracic obstruction, with inspiratory flattening.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. COPD:&nbsp;</strong>Leads to a concave or \"scooped-out\" expiratory limb, not the fixed flattening throughout the curve.</span></p>",
    "correct_choice_id": 160950,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 60507,
    "choices": [
      {
        "id": 241321,
        "text": "<p><span style=\"font-size:14.0pt;\">Alveolocapillary membrane leakage</span></p>"
      },
      {
        "id": 241322,
        "text": "<p><span style=\"font-size:14.0pt;\">Intrapulmonary left-to-right shunt</span></p>"
      },
      {
        "id": 241323,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased production of surfactant</span></p>"
      },
      {
        "id": 241324,
        "text": "<p><span style=\"font-size:14.0pt;\">Embolic obstruction of pulmonary arteries</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old woman is brought to the emergency department because of a 2-day history of severe epigastric pain and nausea. She has a 20-year history of alcohol use disorder. Nine hours after admission, she becomes increasingly dyspneic and tachypneic. Pulse oximetry on supplemental oxygen shows an oxygen saturation of 81%. Physical examination shows diffuse lung crackles, marked epigastric tenderness, and a periumbilical hematoma. Laboratory studies show normal brain natriuretic peptide. An x-ray of the chest shows bilateral opacities in the lower lung fields. Which of the following pathomechanisms best explains this patient's pulmonary findings?</span></p>",
    "unique_key": "Q3772644",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417222,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span><span style=\"font-size:12pt;\"><strong> </strong></span><span style=\"font-size:14.0pt;\"><strong>A) Alveolocapillary membrane leakage</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient's presentation is consistent with acute respiratory distress syndrome (ARDS), characterized by alveolocapillary membrane leakage leading to non-cardiogenic pulmonary edema and bilateral infiltrates on chest X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Intrapulmonary left-to-right shunt:&nbsp;</strong>Does not cause hypoxemia and bilateral lung opacities as seen here.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Increased production of surfactant:&nbsp;</strong>Surfactant production is typically decreased in ARDS, worsening lung compliance.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Embolic obstruction of pulmonary arteries:&nbsp;</strong>Pulmonary embolism usually presents with sudden chest pain and localized infarction, not diffuse bilateral opacities.&nbsp;</span></p>",
    "correct_choice_id": 241321,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25760,
    "choices": [
      {
        "id": 102990,
        "text": "<p><span style=\"font-size:14.0pt;\">Obesity hypoventilation syndrome&nbsp;</span></p>"
      },
      {
        "id": 102991,
        "text": "<p><span style=\"font-size:14.0pt;\">Obstructive sleep apnea&nbsp;</span></p>"
      },
      {
        "id": 102992,
        "text": "<p><span style=\"font-size:14.0pt;\">Central sleep apnea&nbsp;</span></p>"
      },
      {
        "id": 102993,
        "text": "<p><span style=\"font-size:14.0pt;\">Narcolepsy&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A woman came in with complaints of excessive daytime sleepiness and difficulties in concentration and memory persisting for a year. During the examination, her Body Mass Index (BMI) was measured at 43 kg/m<sup>2</sup>, and her blood pressure (BP) was recorded as 170/98 mmHg. Arterial Blood Gas (ABG) analysis was performed while she was awake, and the results are as follows. Based on the provided information, what is the probable diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:18px;\">PaO<sub>2</sub> \u2013 70 mmHg</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">PaCO<sub>2</sub> \u2013 53 mmHg</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">HCO<sub>3</sub><sup>-</sup> - 33 mmHg</span></p>",
    "unique_key": "Q8283223",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417223,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Obesity hypoventilation syndrome&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Obesity hypoventilation syndrome presents with daytime hypercapnia (elevated PaCO2), hypoxemia, and metabolic compensation (elevated HCO3-) due to chronic hypoventilation in obese patients.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Obstructive sleep apnea:&nbsp;</strong>Typically presents with intermittent nocturnal hypoxia but normal daytime blood gases.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Central sleep apnea:&nbsp;</strong>Characterized by cessation of respiratory effort during sleep, less common in obesity.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Narcolepsy:&nbsp;</strong>A sleep disorder presenting with excessive daytime sleepiness but without blood gas abnormalities.&nbsp;</span></p>",
    "correct_choice_id": 102990,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29146,
    "choices": [
      {
        "id": 116490,
        "text": "<p><span style=\"font-size:14.0pt;\">+10 cm H2O</span></p>"
      },
      {
        "id": 116491,
        "text": "<p><span style=\"font-size:14.0pt;\">+ 5 cm H2O</span></p>"
      },
      {
        "id": 116492,
        "text": "<p><span style=\"font-size:14.0pt;\">-5cm H20</span></p>"
      },
      {
        "id": 116493,
        "text": "<p><span style=\"font-size:14.0pt;\">0cm H20</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">The combined compliance of the lung and chest wall of a healthy individual is measured and plotted as shown below. It is noted that the intrapleural pressure at the end of maximal inspiration is -8 cm H20 (marked x). Which of the following is the best estimate of the intrapleural pressure at the point marked by the black dot?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture4.jpg\" alt=\"\" width=\"300\" height=\"296\"></span></p>",
    "unique_key": "Q2762074",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417224,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) -5cm H20</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">At the point marked by the black dot, which represents normal end-expiratory or functional residual capacity (FRC), the&nbsp;intrapleural pressure&nbsp;is approximately&nbsp;-5 cm H\u2082O. This negative pressure keeps the lung expanded and prevents collapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. +10 cm H\u2082O:&nbsp;</strong>This would indicate a highly positive pressure, which does not occur physiologically within the pleural space.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. +5 cm H\u2082O:&nbsp;</strong>Pleural pressure is not positive in normal respiratory physiology at FRC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 0 cm H\u2082O:&nbsp;</strong>Occurs with tension pneumothorax or lung collapse, not at equilibrium in a healthy individual.</span></p>",
    "correct_choice_id": 116492,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29151,
    "choices": [
      {
        "id": 116510,
        "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
      },
      {
        "id": 116511,
        "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
      },
      {
        "id": 116512,
        "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
      },
      {
        "id": 116513,
        "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Physicians conduct a series of animal experiments to determine pulmonary tissue regeneration capacity. During one of the experiments, lung alveoli are exposed to NO2 and massive necrosis of the epithelial lining ensues. Histologic examination of the injured tissues a month later shows partial recovery of the alveolar epithelial lining. This regenerated tissue is most likely derived from which of the following cells?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture5.jpg\" alt=\"\" width=\"300\" height=\"222\"></span></p>",
    "unique_key": "Q2299214",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417225,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Label B marks&nbsp;type II pneumocytes, which function as the stem cells of the alveolar epithelium. After injury, type II pneumocytes proliferate and differentiate into type I pneumocytes, regenerating the alveolar lining and restoring epithelial integrity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A:&nbsp;</strong>Type I pneumocytes\u2014flattened cells involved in gas exchange and cannot regenerate the epithelium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. C:</strong>&nbsp;Alveoli represented by empty air filled space</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. D:&nbsp;</strong>Capillary endothelial cells, play a role in gas exchange but not in epithelial regeneration.</span></p>",
    "correct_choice_id": 116511,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29197,
    "choices": [
      {
        "id": 116694,
        "text": "<p><span style=\"font-size:14.0pt;\">Increase, decrease, increase</span></p>"
      },
      {
        "id": 116695,
        "text": "<p><span style=\"font-size:14.0pt;\">Increase, increase, increase</span></p>"
      },
      {
        "id": 116696,
        "text": "<p><span style=\"font-size:14.0pt;\">Increase, unchanged, decrease</span></p>"
      },
      {
        "id": 116697,
        "text": "<p><span style=\"font-size:14.0pt;\">Decrease, decrease, increase</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 70-year-old woman has been enrolled in a longitudinal research study on aging for the last 30 years. Medical history is significant for osteoporosis; she has developed moderate kyphosis due to gradual loss of vertebral body height. She is otherwise active and healthy with no additional medical issues. She has never smoked. Compared to her physiology testing done years ago, which of the following changes is most consistent with normal aging in 1) lung compliance, 2) total respiratory system compliance and 3) physiologic dead space respectively?</span></p>",
    "unique_key": "Q9058228",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417226,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Increase, decrease, increase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">With aging, lung compliance increases due to loss of elastic tissue, but total respiratory system compliance decreases because of chest wall stiffening. Physiologic dead space increases due to changes in ventilation-perfusion matching.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Increase, increase, increase:&nbsp;</strong>Incorrect; total respiratory system compliance decreases with age due to chest wall changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Increase, unchanged, decrease:&nbsp;</strong>Incorrect; total compliance does not remain unchanged and dead space tends to increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Decrease, decrease, increase:&nbsp;</strong>Incorrect; lung compliance increases, not decreases, with aging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Concept of lung compliance is important in OLD and RLD:</span></p>",
    "correct_choice_id": 116694,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29207,
    "choices": [
      {
        "id": 116734,
        "text": "<p><span style=\"font-size:14.0pt;\">Bleeding from hypertrophied bronchial arteries</span></p>"
      },
      {
        "id": 116735,
        "text": "<p><span style=\"font-size:14.0pt;\">Blood loss from hypertrophied pulmonary arteries</span></p>"
      },
      {
        "id": 116736,
        "text": "<p><span style=\"font-size:14.0pt;\">Diffuse alveolar hemorrhage due to vasculitis</span></p>"
      },
      {
        "id": 116737,
        "text": "<p><span style=\"font-size:14.0pt;\">Formation of a fistula between the tracheobronchial tree and aorta</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 17-year-old girl is brought to the emergency department due to hemoptysis and severe respiratory distress. The patient has been on several oral antibiotics for pneumonia over the past week and has required numerous similar treatments in the past. Pulmonary examination reveals diffusely reduced air flow, rales, and intercostal retractions. Despite aggressive management, the patient ultimately expires. An autopsy is performed and a gross lung specimen is shown in the image below:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture100.jpg\" alt=\"\" width=\"300\" height=\"512\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Which of the following is the most likely etiology of this patient's hemoptysis?</span></p>",
    "unique_key": "Q4580735",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417227,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Bleeding from hypertrophied bronchial arteries</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The gross lung specimen reveals extensive cystic changes and dilated airways, consistent with advanced&nbsp;bronchiectasis. In this condition, repeated infections cause hypertrophy of the bronchial arteries, which are the usual source of significant hemoptysis in affected patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Blood loss from hypertrophied pulmonary arteries:&nbsp;</strong>Pulmonary arteries do not typically hypertrophy or bleed in bronchiectasis; hemoptysis from pulmonary arteries is less common.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diffuse alveolar hemorrhage due to vasculitis:&nbsp;</strong>This presents with diffuse infiltrates and is associated with conditions like Goodpasture's or Wegener's, not the cystic bronchiectatic changes seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Formation of a fistula between the tracheobronchial tree and aorta:&nbsp;</strong>Extremely rare and would present acutely, not with chronic pulmonary changes.</span></p>",
    "correct_choice_id": 116734,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29224,
    "choices": [
      {
        "id": 116802,
        "text": "<p><span style=\"font-size:12.0pt;\">Low</span></p>"
      },
      {
        "id": 116803,
        "text": "<p><span style=\"font-size:12.0pt;\">High</span></p>"
      },
      {
        "id": 116804,
        "text": "<p><span style=\"font-size:12.0pt;\">Moderate</span></p>"
      },
      {
        "id": 116805,
        "text": "<p><span style=\"font-size:12.0pt;\">Cannot comment without d-dimer values</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 53-year-old woman underwent hip replacement surgery. A week after the surgery, the patient developed swelling of the legs associated with pain on palpation. Her heart rate is 70 beats per min. There is no history of hemoptysis or significant weight loss. There is no previous history of pulmonary embolism. What is the risk of developing pulmonary embolism in the patient based on Well's score?</span></p>",
    "unique_key": "Q8449116",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417228,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) High</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recent surgery and unilateral leg swelling contribute significantly to the Well\u2019s score, placing the patient at high risk for pulmonary embolism even without other symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Low:&nbsp;</strong>Incorrect; postoperative leg swelling increases risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Moderate:&nbsp;</strong>Risk is higher due to surgery and symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cannot comment without d-dimer values:&nbsp;</strong>Well\u2019s score risk stratification does not require d-dimer for initial assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Wells Score for Pulmonary Embolism</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_l1gFm5m.png\" width=\"492\" height=\"236\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Interpretation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Low Risk:</strong> &lt; 2 points</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intermediate Risk:</strong> 2\u20136 points</span></li><li><span style=\"font-size:14.0pt;\"><strong>High Risk:</strong> &gt; 6 points</span></li><li><span style=\"font-size:14.0pt;\"><strong>PE unlikely:</strong> 0\u20134 points</span></li><li><span style=\"font-size:14.0pt;\"><strong>PE likely:</strong> &gt; 4 points</span></li></ul>",
    "correct_choice_id": 116803,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29237,
    "choices": [
      {
        "id": 116854,
        "text": "<p><span style=\"font-size:14.0pt;\">Adenovirus</span></p>"
      },
      {
        "id": 116855,
        "text": "<p><span style=\"font-size:14.0pt;\">Aspergillus fumigatus</span></p>"
      },
      {
        "id": 116856,
        "text": "<p><span style=\"font-size:14.0pt;\">Strongyloides</span></p>"
      },
      {
        "id": 116857,
        "text": "<p><span style=\"font-size:14.0pt;\">Paragonimus</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 34-year-old woman comes to the office for evaluation of recurrent transient pulmonary infiltrates. The patient has a history of bronchial asthma and has had several exacerbations over the past few years, particularly during the winter months. Her medications include albuterol as needed and medium-dose inhaled glucocorticoids. Complete blood count shows eosinophilia. A chest CT scan reveals proximal bronchiectasis. This patient's condition is most likely related to colonization with which of the following?</span></p>",
    "unique_key": "Q9870300",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417229,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Aspergillus fumigatus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Allergic bronchopulmonary aspergillosis (ABPA) occurs in asthmatics and causes proximal bronchiectasis, eosinophilia, and recurrent infiltrates due to hypersensitivity to Aspergillus colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adenovirus:&nbsp;</strong>Not typically associated with bronchiectasis or eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Strongyloides:&nbsp;</strong>Causes eosinophilia but not bronchiectasis or recurrent infiltrates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Paragonimus:&nbsp;</strong>Can cause pulmonary symptoms but not characteristic proximal bronchiectasis.</span></p>",
    "correct_choice_id": 116855,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29257,
    "choices": [
      {
        "id": 116934,
        "text": "<p><span style=\"font-size:14.0pt;\">Alveolar hyperdistention</span></p>"
      },
      {
        "id": 116935,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased cardiac output</span></p>"
      },
      {
        "id": 116936,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased functional residual capacity</span></p>"
      },
      {
        "id": 116937,
        "text": "<p><span style=\"font-size:14.0pt;\">Improved ventilation-perfusion matching</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 55-year-old woman with a history of Crohn disease is admitted to the hospital due to perforated appendicitis. The patient quickly develops respiratory difficulty, and acute respiratory distress syndrome is diagnosed. She is intubated and mechanically ventilated with positive pressure ventilation. She is intermittently placed in the prone position while mechanically ventilated. Which of the following is most likely to occur due to this position change?</span></p>",
    "unique_key": "Q1478711",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417230,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Improved ventilation-perfusion matching</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Prone positioning redistributes lung perfusion and ventilation, improving oxygenation by reducing lung compression and enhancing ventilation-perfusion matching in ARDS patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Alveolar hyperdistention:&nbsp;</strong>Not typically associated with prone positioning; often minimized by lung-protective ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Decreased cardiac output:&nbsp;</strong>May occur but is generally outweighed by oxygenation benefits.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreased functional residual capacity:&nbsp;</strong>Prone position tends to maintain or improve functional residual capacity.</span></p>",
    "correct_choice_id": 116937,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29266,
    "choices": [
      {
        "id": 116970,
        "text": "<p><span style=\"font-size:14.0pt;\">Left lower lung lobe</span></p>"
      },
      {
        "id": 116971,
        "text": "<p><span style=\"font-size:14.0pt;\">Left pleural space</span></p>"
      },
      {
        "id": 116972,
        "text": "<p><span style=\"font-size:14.0pt;\">Right middle lung lobe</span></p>"
      },
      {
        "id": 116973,
        "text": "<p><span style=\"font-size:14.0pt;\">Right upper lobe&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 15-year-old girl is admitted for fever, cough, and malaise for the past two days. She has no history of sick contacts, and all her immunizations are up to date. Her leukocyte count is 21,000/mm with 7% band forms. Upright chest x-ray findings are shown in the image below. Which of the following is the most likely location of the pathologic process in this patient?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture83.jpg\" alt=\"\" width=\"300\" height=\"367\"></span></p>",
    "unique_key": "Q2430678",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417231,
    "difficulty_level": "difficult",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Right upper lobe&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The upright lateral chest x-ray demonstrates loss of normal translucency in the&nbsp;right upper lobe. The consolidation and opacification seen here, especially in the upper region of the lung on lateral projection, is most consistent with pneumonia affecting the right upper lobe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Left lower lung lobe:&nbsp;</strong>The opacity is not localized to the left lower lobe; the left lung appears relatively clear in this view.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Left pleural space:&nbsp;</strong>There is no evidence of pleural fluid or a pleural-based abnormality on the left side.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Right middle lung lobe:&nbsp;</strong>The middle lobe occupies a different area on lateral film and would not cause this upper zone opacity.</span></p>",
    "correct_choice_id": 116973,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35560,
    "choices": [
      {
        "id": 142047,
        "text": "<p><span style=\"font-size:14.0pt;\">Allergic inflammation</span></p>"
      },
      {
        "id": 142048,
        "text": "<p><span style=\"font-size:14.0pt;\">Chronic colonization</span></p>"
      },
      {
        "id": 142049,
        "text": "<p><span style=\"font-size:14.0pt;\">Invasive malignancy&nbsp;</span></p>"
      },
      {
        "id": 142050,
        "text": "<p><span style=\"font-size:14.0pt;\">Heterotopic calcification</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">60-year-old man is brought to the emergency department following a motor vehicle collision. He is comatose and unable to provide any information. Multiple blunt injuries of the torso and abdomen are present. Review of the patient's medical record reveals a history of right upper lobe cavitary tuberculosis that was effectively treated several years ago. A representative slice of the chest CT, shown in the image below, redemonstrates his known right upper lobe cavity. Which of the following best describes this patient's condition?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/picture8_PhLSWfi.jpg\" alt=\"\" width=\"300\" height=\"212\"></span></p>",
    "unique_key": "Q6993330",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417232,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Chronic colonization</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of a pre-existing lung cavity from prior tuberculosis is a common site for chronic colonization by fungi such as Aspergillus, forming a fungus ball (aspergilloma) without tissue invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Allergic inflammation:&nbsp;</strong>Refers to allergic bronchopulmonary aspergillosis, which involves airway inflammation, not colonization of a cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Invasive malignancy:&nbsp;</strong>Would show a mass with tissue invasion and destruction, not a noninvasive fungus ball.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Heterotopic calcification:&nbsp;</strong>Refers to abnormal calcification of soft tissues, unrelated to lung cavities.</span></p>",
    "correct_choice_id": 142048,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35574,
    "choices": [
      {
        "id": 142103,
        "text": "<p><span style=\"font-size:14.0pt;\">Dorsal respiratory group&nbsp;</span></p>"
      },
      {
        "id": 142104,
        "text": "<p><span style=\"font-size:14.0pt;\">Nucleus tractus solitarius&nbsp;</span></p>"
      },
      {
        "id": 142105,
        "text": "<p><span style=\"font-size:14.0pt;\">Pneumotaxic center&nbsp;</span></p>"
      },
      {
        "id": 142106,
        "text": "<p><span style=\"font-size:14.0pt;\">Vasomotor center&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:18px;\">A 16-year-old girl with a head injury from a car accident was brought to the emergency department by ambulance. On exam, she had a respiratory rate </span><span style=\"font-size:18px;\">of 8 breaths per minute, and a prolonged duration of inhalation was noted. Damage to which of the following groups of neurons in the brainstem is most likely responsible for this abnormal respiration?</span></p>",
    "unique_key": "Q8361446",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417233,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pneumotaxic center&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The pneumotaxic center regulates the rate and pattern of breathing by limiting inspiration duration; damage leads to prolonged inhalation and decreased respiratory rate.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Dorsal respiratory group:&nbsp;</strong>Controls basic rhythm of inspiration but not inspiratory duration specifically.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Nucleus tractus solitarius:&nbsp;</strong>Processes sensory information related to respiration but not direct control of breathing pattern.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Vasomotor center:&nbsp;</strong>Regulates blood pressure and vascular tone, unrelated to respiration.&nbsp;</span></p>",
    "correct_choice_id": 142105,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35586,
    "choices": [
      {
        "id": 142151,
        "text": "<p><span style=\"font-size:14.0pt;\">Alveolar hyaline membranes</span></p>"
      },
      {
        "id": 142152,
        "text": "<p><span style=\"font-size:14.0pt;\">Birefringent silicate particles</span></p>"
      },
      {
        "id": 142153,
        "text": "<p><span style=\"font-size:14.0pt;\">Carbon-laden macrophages&nbsp;</span></p>"
      },
      {
        "id": 142154,
        "text": "<p><span style=\"font-size:14.0pt;\">Ferruginous bodies</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 76-year-old man is brought to the emergency department after being involved in a motor vehicle collision. He is found to have a laceration of the spleen and is taken for emergent laparotomy. During surgery, the patient goes into cardiac arrest and dies, despite aggressive resuscitation efforts. Autopsy examination is performed and shows areas of thickening inside the chest wall as shown below. Lung examination shows fibrosis of the lower lobes. Pathologic examination of these fibrotic areas is most likely to reveal which of the following findings?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/picture13_I1W3S7E.jpg\" alt=\"\" width=\"300\" height=\"245\"></span></p>",
    "unique_key": "Q7649795",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417234,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ferruginous bodies</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The thickening of the chest wall and lower lobe pulmonary fibrosis in the autopsy suggests asbestosis. Ferruginous bodies, iron-coated asbestos fibers, are characteristic histologic findings in asbestosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Alveolar hyaline membranes:&nbsp;</strong>Found in diffuse alveolar damage/acute respiratory distress syndrome, not chronic fibrosis from asbestos.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Birefringent silicate particles:&nbsp;</strong>Seen in silicosis caused by inhalation of silica dust.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Carbon-laden macrophages:&nbsp;</strong>Found in coal workers\u2019 pneumoconiosis or anthracosis, related to coal dust exposure.</span></p>",
    "correct_choice_id": 142154,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35590,
    "choices": [
      {
        "id": 142167,
        "text": "<p><span style=\"font-size:14.0pt;\">Bilateral atelectasis</span></p>"
      },
      {
        "id": 142168,
        "text": "<p><span style=\"font-size:14.0pt;\">Left ventricular failure</span></p>"
      },
      {
        "id": 142169,
        "text": "<p><span style=\"font-size:14.0pt;\">Obstructive lung disease</span></p>"
      },
      {
        "id": 142170,
        "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary fibrosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 58-year-old man comes to the OPD due to exertional dyspnea and cough. His symptoms started 6 months ago and have progressively worsened. Other medical conditions include peptic ulcer disease, and rheumatoid arthritis. The patient had taken a medication for rheumatoid arthritis for many years but stopped a year ago, as the drug failed to improve his worsening hand arthritis. Chest x-ray is shown in the image below. Which of the following is the most likely explanation for this patient's pulmonary symptoms?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/picture16_Pg5yGfz.jpg\" alt=\"\" width=\"300\" height=\"250\"></span></p>",
    "unique_key": "Q2021420",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417235,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Pulmonary fibrosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The patient's gradual onset exertional dyspnea, dry cough, history of rheumatoid arthritis, and chest X-ray findings suggest pulmonary fibrosis, which is a common extra-articular manifestation of rheumatoid arthritis and can cause progressive restrictive lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><strong>Option A. Bilateral atelectasis:&nbsp;</strong>Would present acutely with volume loss and more focal x-ray changes, not progressive symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Left ventricular failure:&nbsp;</strong>Causes pulmonary edema with signs of cardiomegaly and vascular redistribution on X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Obstructive lung disease:&nbsp;</strong>Characterized by hyperinflation and airway obstruction, typically seen in COPD or asthma, not fibrosis.</span></p>",
    "correct_choice_id": 142170,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35629,
    "choices": [
      {
        "id": 142323,
        "text": "<p><span style=\"font-size:14.0pt;\">Compliance low, FRC high, Airway resistance high&nbsp;</span></p>"
      },
      {
        "id": 142324,
        "text": "<p><span style=\"font-size:14.0pt;\">Compliance low, FRC low, Airway resistance high&nbsp;</span></p>"
      },
      {
        "id": 142325,
        "text": "<p><span style=\"font-size:14.0pt;\">Compliance high, FRC high, Airway resistance high&nbsp;</span></p>"
      },
      {
        "id": 142326,
        "text": "<p><span style=\"font-size:14.0pt;\">Compliance high, FRC high, Airway resistance low&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 1-hour-old boy born at 29 weeks gestation via cesarean delivery due to maternal preeclampsia with severe features, is admitted to the neonatal intensive care unit for respiratory failure. Which of the following best describes the condition of this patient's lungs compared to a normal neonate?</span></p>",
    "unique_key": "Q5477618",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417236,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Compliance low, FRC low, Airway resistance high&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Premature neonates typically have decreased lung compliance and lower functional residual capacity (FRC) due to immature surfactant production. Airway resistance is increased due to smaller airway caliber and immature lung structure.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Compliance low, FRC high, Airway resistance high:&nbsp;</strong>FRC is usually low, not high, in preterm infants.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Compliance high, FRC high, Airway resistance high:&nbsp;</strong>Compliance is typically low in premature lungs.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Compliance high, FRC high, Airway resistance low:&nbsp;</strong>Both compliance and FRC are decreased in premature infants with respiratory failure.&nbsp;</span></p>",
    "correct_choice_id": 142324,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57563,
    "choices": [
      {
        "id": 229621,
        "text": "<p><span style=\"font-size:14.0pt;\">Miosis</span></p>"
      },
      {
        "id": 229622,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypoglycemia</span></p>"
      },
      {
        "id": 229623,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypokalemia</span></p>"
      },
      {
        "id": 229624,
        "text": "<p><span style=\"font-size:14.0pt;\">Bradycardia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 23-year-old woman with asthma is brought to the emergency department because of shortness of breath and wheezing for 20 minutes. She is unable to speak more than a few words at a time. Treatment with high-dose continuous inhaled albuterol is begun. This patient is at increased risk for which of the following adverse effects?</span></p>",
    "unique_key": "Q8430855",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417406,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hypokalemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Beta-2 agonists like albuterol drive potassium into cells, causing hypokalemia as a common adverse effect during high-dose or continuous treatment.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Miosis:&nbsp;</strong>Not associated with beta-2 agonist use.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Hypoglycemia:&nbsp;</strong>Beta-2 agonists can cause hyperglycemia due to glycogenolysis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Bradycardia:&nbsp;</strong>Beta-2 agonists more commonly cause tachycardia, not bradycardia.&nbsp;</span></p>",
    "correct_choice_id": 229623,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 66988,
    "choices": [
      {
        "id": 267085,
        "text": "<p><span style=\"font-size:14.0pt;\">Legionella pneumophila</span></p>"
      },
      {
        "id": 267086,
        "text": "<p><span style=\"font-size:14.0pt;\">Klebsiella pneumoniae</span></p>"
      },
      {
        "id": 267087,
        "text": "<p><span style=\"font-size:14.0pt;\">Haemophilus influenzae</span></p>"
      },
      {
        "id": 267088,
        "text": "<p><span style=\"font-size:14.0pt;\">Mycoplasma pneumoniae</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 17-year-old girl presents to the clinic with headache, fatigue, fever, and a persistent dry cough. She reports that the symptoms began 2 weeks ago during a school trip. A chest X-ray reveals diffuse interstitial infiltrates. Laboratory testing shows hemolytic anemia with elevated reticulocyte count. Blood samples drawn into anticoagulated tubes are stored on ice, and visible clumping is observed when cold. Which of the following pathogens is the most likely cause of this patient's condition?</span></p>",
    "unique_key": "Q7710243",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417407,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Mycoplasma pneumoniae&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mycoplasma pneumoniae infection can cause atypical pneumonia with diffuse interstitial infiltrates and cold agglutinin autoimmune hemolytic anemia, as indicated by clumping of red cells at cold temperatures.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Legionella pneumophila:&nbsp;</strong>Causes severe atypical pneumonia but not associated with cold agglutinins.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Klebsiella pneumoniae:&nbsp;</strong>Typically causes lobar pneumonia, not interstitial infiltrates.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Haemophilus influenzae:&nbsp;</strong>Associated with bacterial pneumonia but not cold agglutinin hemolytic anemia.&nbsp;</span></p>",
    "correct_choice_id": 267088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57302,
    "choices": [
      {
        "id": 228585,
        "text": "<p><span style=\"font-size:18px;\">Oral candidiasis is common with its use.</span></p>"
      },
      {
        "id": 228586,
        "text": "<p><span style=\"font-size:18px;\">It has fewer side effects than other inhalational corticosteroids.</span></p>"
      },
      {
        "id": 228587,
        "text": "<p><span style=\"font-size:18px;\">It is a prodrug activated by bronchial esterase.</span></p>"
      },
      {
        "id": 228588,
        "text": "<p><span style=\"font-size:18px;\">It has comparable efficacy to other inhalational corticosteroids.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following statements about Ciclesonide is incorrect? (NEET PG 2024)</span></p>",
    "unique_key": "Q6621531",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417408,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Oral candidiasis is common with its use.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Ciclesonide is an inhalational corticosteroid used to manage asthma and other respiratory conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">It is unique among inhaled corticosteroids because it is a <strong>\"soft steroid\"</strong> and functions as a prodrug. This means that Ciclesonide is inactive when administered and only becomes active when it reaches the lungs, where it is <strong>converted into its active form by bronchial esterases</strong>. This activation in the target site, the bronchial airways, significantly reduces the drug's systemic side effects, including the risk of oral candidiasis, which is common with other inhaled corticosteroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Because the majority of the drug that deposits in the oropharynx remains inactive, the likelihood of developing oral candidiasis (a common side effect of other inhalational steroids due to local immunosuppression) is significantly lower with Ciclesonide.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. It has fewer side effects than other inhalational corticosteroids:</strong> This statement is correct. Due to its activation in the bronchial tree, Ciclesonide has fewer systemic and local side effects compared to other inhalational corticosteroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. It is a prodrug activated by bronchial esterase:</strong> This is also correct. Ciclesonide remains inactive until it reaches the lungs, where it is converted into its active form by bronchial esterases.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. It has comparable efficacy to other inhalational corticosteroids:</strong> This is correct. Ciclesonide is just as effective as other inhalational corticosteroids in managing respiratory conditions such as asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Ciclesonide, a prodrug inhalational corticosteroid, has a lower risk of causing oral candidiasis compared to other inhalational steroids because it remains inactive until it reaches the lungs, where it is activated by bronchial esterases.</span></p>",
    "correct_choice_id": 228585,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 67019,
    "choices": [
      {
        "id": 267209,
        "text": "<p><span style=\"font-size:14.0pt;\">Chloride&nbsp;</span></p>"
      },
      {
        "id": 267210,
        "text": "<p><span style=\"font-size:14.0pt;\">Oxygen&nbsp;</span></p>"
      },
      {
        "id": 267211,
        "text": "<p><span style=\"font-size:14.0pt;\">Phosphate&nbsp;</span></p>"
      },
      {
        "id": 267212,
        "text": "<p><span style=\"font-size:14.0pt;\">Protons&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Physiologists studying hemoglobin function in patients with respiratory disorders are evaluating changes associated with oxygen loading and unloading. During the transition from point 1 to point 2 on the graph shown below, hemoglobin molecules are most likely to release which of the following?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202024-12-19%20at%207.15.49%20PM.jpeg\" width=\"1350\" height=\"1272\"></span></p>",
    "unique_key": "Q2582050",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417409,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Protons&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During oxygen unloading (from point 1 to point 2 on the oxygen-hemoglobin dissociation curve), hemoglobin releases protons (H+), which contribute to the Bohr effect facilitating oxygen release in tissues.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chloride:</strong> Chloride ions (chloride shift) enter red blood cells during CO2 transport but are not directly released during oxygen unloading.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Oxygen:</strong> Oxygen is released by hemoglobin, but the question asks which molecule is released by hemoglobin apart from oxygen during this transition.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Phosphate:</strong> Phosphate 2,3-Bisphosphoglycerate binds to deoxygenated hemoglobin but is not released during oxygen unloading.</span></p>",
    "correct_choice_id": 267212,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85693,
    "choices": [
      {
        "id": 341308,
        "text": "<p><span style=\"font-size:14.0pt;\">Prevents overinflation during deep inspiration</span></p>"
      },
      {
        "id": 341309,
        "text": "<p><span style=\"font-size:14.0pt;\">Promotes high lung volumes for efficient gas exchange</span></p>"
      },
      {
        "id": 341310,
        "text": "<p><span style=\"font-size:14.0pt;\">Prevents atelectasis during expiration</span></p>"
      },
      {
        "id": 341311,
        "text": "<p><span style=\"font-size:14.0pt;\">Reduces unnecessary energy expenditure</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All are advantages of the Hering-Breuer reflex, except:</span></p>",
    "unique_key": "Q5326163",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417410,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Promotes high lung volumes for efficient gas exchange</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Hering-Breuer reflex primarily prevents overinflation and regulates breathing depth; it does not promote high lung volumes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hering\u2013Breuer Reflex</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Overstretched lungs</strong></span><br><span style=\"font-size:14.0pt;\">\u2193</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stretch receptors</strong></span><br><span style=\"font-size:14.0pt;\">(Visceral pleura, bronchi, alveoli)</span><br><span style=\"font-size:14.0pt;\">\u2193 <i>Impulses through vagus nerve</i></span></li><li><span style=\"font-size:14.0pt;\"><strong>Respiratory center</strong></span><br><span style=\"font-size:14.0pt;\">(Inhibits inspiratory center)</span><br><span style=\"font-size:14.0pt;\">\u2193</span></li><li><span style=\"font-size:14.0pt;\"><strong>Inspiration is stopped</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Prevents overinflation during deep inspiration:&nbsp;</strong>True; reflex inhibits inspiration when lung stretch receptors are activated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Prevents atelectasis during expiration:&nbsp;</strong>Reflex maintains adequate lung volume by controlling expiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Reduces unnecessary energy expenditure:&nbsp;</strong>Helps optimize breathing effort by modulating respiratory rhythm.</span></p>",
    "correct_choice_id": 341309,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 85710,
    "choices": [
      {
        "id": 341376,
        "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary emphysema</span></p>"
      },
      {
        "id": 341377,
        "text": "<p><span style=\"font-size:14.0pt;\">Normal aging</span></p>"
      },
      {
        "id": 341378,
        "text": "<p><span style=\"font-size:14.0pt;\">Inspiration</span></p>"
      },
      {
        "id": 341379,
        "text": "<p><span style=\"font-size:14.0pt;\">Saline-filled lung inflation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following increase lung compliance, except:</span></p>",
    "unique_key": "Q8656165",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417411,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inspiration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Inspiration decreases lung compliance temporarily because the lung tissue is stretched; lung compliance is measured during passive expiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pulmonary emphysema:&nbsp;</strong>Destroys elastic tissue causing increased compliance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Normal aging:&nbsp;</strong>Loss of elastic recoil increases lung compliance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Saline-filled lung inflation:&nbsp;</strong>Eliminates air-liquid interface surface tension thus increasing compliance.</span></p>",
    "correct_choice_id": 341378,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92200,
    "choices": [
      {
        "id": 367116,
        "text": "<p><span style=\"font-size:14.0pt;\">Resistance to rifampicin and sensitive to fluoroquinolones</span></p>"
      },
      {
        "id": 367117,
        "text": "<p><span style=\"font-size:14.0pt;\">Extrapulmonary TB like tubercular meningitis</span></p>"
      },
      {
        "id": 367118,
        "text": "<p><span style=\"font-size:14.0pt;\">Mutation only to INH A and kat G gene</span></p>"
      },
      {
        "id": 367119,
        "text": "<p><span style=\"font-size:14.0pt;\">Rifampicin sensitive</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">For MDR-RR TB, what is the indication of short course bedaquiline?</span></p>",
    "unique_key": "Q2294874",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417492,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Resistance to rifampicin and sensitive to fluoroquinolones</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Short course bedaquiline is indicated for multidrug-resistant rifampicin-resistant TB strains that remain sensitive to fluoroquinolones.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Extrapulmonary TB like tubercular meningitis</strong>: Bedaquiline is not the first choice in meningitis due to poor CNS penetration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mutation only to INH A and kat G gene:&nbsp;</strong>This scenario indicates isoniazid resistance but rifampicin sensitivity; bedaquiline is targeted at rifampicin resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rifampicin sensitive:&nbsp;</strong>Standard first-line therapy is preferred for rifampicin-sensitive TB.</span></p>",
    "correct_choice_id": 367116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74332,
    "choices": [
      {
        "id": 296249,
        "text": "<p><span style=\"font-size:14.0pt;\">Vocal cord palsy</span></p>"
      },
      {
        "id": 296250,
        "text": "<p><span style=\"font-size:14.0pt;\">Bronchial asthma</span></p>"
      },
      {
        "id": 296251,
        "text": "<p><span style=\"font-size:14.0pt;\">Morbid obesity</span></p>"
      },
      {
        "id": 296252,
        "text": "<p><span style=\"font-size:14.0pt;\">Emphysema</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The flow volume curve after spirometry in patient 1 is given below. The most likely diagnosis in this patient is:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-15%20124842.jpg\" width=\"491\" height=\"313\"></span></p>",
    "unique_key": "Q6721423",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417493,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Morbid obesity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Morbid obesity causes a restrictive pattern on spirometry characterized by reduced lung volumes with preserved flow rates, resulting in a flow-volume curve with decreased volumes but relatively normal shape, consistent with restriction rather than obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vocal cord palsy:&nbsp;</strong>Typically produces variable extrathoracic obstruction with flattening of the inspiratory limb on flow-volume curve.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bronchial asthma:&nbsp;</strong>Shows obstructive pattern with reduced expiratory flow and scooped-out appearance of the curve.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Emphysema:&nbsp;</strong>An obstructive pattern characterized by reduced flow rates and increased lung volumes with a concave expiratory limb.</span></p>",
    "correct_choice_id": 296251,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74339,
    "choices": [
      {
        "id": 296277,
        "text": "<p><span style=\"font-size:14.0pt;\">Cannon a waves on JVP</span></p>"
      },
      {
        "id": 296278,
        "text": "<p><span style=\"font-size:14.0pt;\">Raised troponin levels&nbsp;</span></p>"
      },
      {
        "id": 296279,
        "text": "<p><span style=\"font-size:14.0pt;\">Mediastinal widening&nbsp;</span></p>"
      },
      {
        "id": 296280,
        "text": "<p><span style=\"font-size:14.0pt;\">Filling defect in PA on CTPA</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 53-year-old woman is brought to the emergency department after she collapsed suddenly while standing. She also reports left-sided chest pain. The patient was recently diagnosed with colon cancer on a routine colonoscopy and has been on bed rest since then. Her blood pressure is 86/50 mm Hg and pulse is 120/min and regular. Pulse oximetry shows 80% on room air. She is diaphoretic and tachypneic. Jugular venous pressure is 13 cm HO. Further workup in this patient would most likely show which of the following?</span></p>",
    "unique_key": "Q8312418",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417494,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Filling defect in PA on CTPA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical picture suggests massive pulmonary embolism, and a filling defect in the pulmonary artery on computed tomography pulmonary angiography (CTPA) confirms the diagnosis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Cannon a waves on JVP:&nbsp;</strong>Typically seen in complete heart block or AV dissociation, not specific here.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Raised troponin levels:&nbsp;</strong>May occur due to RV strain but are nonspecific and secondary findings.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Mediastinal widening:&nbsp;</strong>More suggestive of aortic dissection, not pulmonary embolism.&nbsp;</span></p>",
    "correct_choice_id": 296280,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92201,
    "choices": [
      {
        "id": 367120,
        "text": "<p><span style=\"font-size:14.0pt;\">High resolution CT&nbsp;</span></p>"
      },
      {
        "id": 367121,
        "text": "<p><span style=\"font-size:14.0pt;\">Chest X-Ray&nbsp;</span></p>"
      },
      {
        "id": 367122,
        "text": "<p><span style=\"font-size:14.0pt;\">CECT&nbsp;</span></p>"
      },
      {
        "id": 367123,
        "text": "<p><span style=\"font-size:14.0pt;\">Low dose CT&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with a 35 pack-year history of smoking presented for a routine check-up. His brother was diagnosed with lung cancer at a similar age. Which of the following would be preferred to screen him for lung cancer?&nbsp;&nbsp;</span></p>",
    "unique_key": "Q3067369",
    "question_audio": null,
    "question_video": null,
    "map_id": 33417495,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Low dose CT</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Low dose CT is the preferred screening modality for high-risk individuals due to its sensitivity in detecting early lung cancers with reduced radiation exposure.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;High resolution CT:&nbsp;</strong>Used primarily for interstitial lung diseases, not screening.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Chest X-Ray:&nbsp;</strong>Less sensitive and not recommended for lung cancer screening.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;CECT:&nbsp;</strong>Higher radiation dose and contrast use; not preferred for routine screening.&nbsp;</span></p>",
    "correct_choice_id": 367123,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Integrated - Respi Endocrine - 03-09-2025';
        const quizFilename = 'integrated-respi-endocrine-03-09-2025-9d6264a7.html';
        let hierarchy = ["Cerebellum", "Mock Test", "BTR"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>